Ref_ID,Title,Authors,Year,Journal,Volume,Start_page,End_page,PubMed,Comment,Other_infos
1,"Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations",Bardeesy N;Falkoff D;Petruzzi MJ;Nowak N;Zabel B;Adam M;Aguiar MC;Grundy P;Shows T;Pelletier J;,1994,Nat Genet,7,91,97,8075648,,
2,Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families,Birch JM;Hartley AL;Tricker KJ;Prosser J;Condie A;Kelsey AM;Harris M;Jones PH;Binchy A;Crowther D;,1994,Cancer Res,54,1298,1304,8118819,"DNA, direct+HOT, ex1-11",updated from ref 86
2,Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families,Birch JM;Hartley AL;Tricker KJ;Prosser J;Condie A;Kelsey AM;Harris M;Jones PH;Binchy A;Crowther D;,1994,Cancer Res,54,1298,1304,8118819,"DNA, direct+HOT, ex1-11",updated from ref 64 and 86
3,Screening for germ line TP53 mutations in breast cancer patients,Borresen AL;Andersen TI;Garber J;Barbier-Piraux N;Thorlacius S;Eyfjord J;Ottestad L;Smith-Sorensen B;Hovig E;Malkin D;,1992,Cancer Res,52,3234,3236,1591732,,
4,Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer,Brugieres L;Gardes M;Moutou C;Chompret A;Meresse V;Martin A;Poisson N;Flamant F;Bonaiti-Pellie C;Lemerle J;,1993,Cancer Res,53,452,455,8425176,,
5,p53 mutations in breast cancer,Coles C;Condie A;Chetty U;Steel CM;Evans HJ;Prosser J;,1992,Cancer Res,52,5291,5298,1394133,,
6,Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma,Diller L;Sexsmith E;Gottlieb A;Li FP;Malkin D;,1995,J Clin Invest,95,1606,1611,7706467,,
7,Constitutional mutation in exon 8 of the p53 gene in a patient with multiple primary tumours: molecular and immunohistochemical findings,Eeles RA;Warren W;Knee G;Bartek J;Averill D;Stratton MR;Blake PR;Tait DM;Lane DP;Easton DF;,1993,Oncogene,8,1269,1276,8479749,,
8,Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia,Felix CA;Nau MM;Takahashi T;Mitsudomi T;Chiba I;Poplack DG;Reaman GH;Cole DE;Letterio JJ;Whang-Peng J;,1992,J Clin Invest,89,640,647,1737852,,
9,A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm,Felix CA;Strauss EA;D'Amico D;Tsokos M;Winter S;Mitsudomi T;Nau MM;Brown DL;Leahey AM;Horowitz ME;,1993,Oncogene,8,1203,1210,8479743,,
10,"A simple p53 functional assay for screening cell lines, blood, and tumors",Flaman JM;Frebourg T;Moreau V;Charbonnier F;Martin C;Chappuis P;Sappino APLIM;Bron L;Benhattar J;Tada M;Van Meir EG;Estreicher A;Iggo RD;,1995,Proc Natl Acad Sci U S A,92,3963,3967,7732013,,
11,Germ-Line p53 mutations in 15 families with Li-Fraumeni syndrome,Frebourg T;Barbier N;Yan YX;Garber JE;Dreyfus M;Fraumeni J Jr;Li FP;Friend SH;,1995,Am J Hum Genet,56,608,615,7887414,"DNA, cloning, ex2-11",
12,Novel germline mutation of the p53 tumor suppressor gene in a child with incidentally discovered adrenal cortical carcinoma,Grayson GH;Moore S;Schneider BG;Saldivar V;Hensel CH;,1994,Am J Pediatr Hematol Oncol,16,341,347,7978053,,
13,A de novo p53 germline mutation affecting codon 151 in a six year old child with multiple tumors,Gutierrez MI;Bhatia KG;Barreiro C;Spangler G;Schvartzmann E;Muriel FS;Magrath IT;,1994,Hum Mol Genet,3,2247,2248,7881428,,
14,Single base pair germ-line deletion in the p53 gene in a cancer predisposed family,Hamelin R;Barichard F;Henry I;Junien C;Thomas G;,1994,Hum Genet,94,88,90,8034301,,
15,Predominantly tumor-limited expression of a mutant allele in a Japanese family carrying a germline p53 mutation,Horio Y;Suzuki H;Ueda R;Koshikawa T;Sugiura T;Ariyoshi Y;Shimokata K;Takahashi T;Takahashi T;,1994,Oncogene,9,1231,1235,8134126,,
16,Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma,Iavarone A;Matthay KK;Steinkirchner TM;Israel MA;,1992,Proc Natl Acad Sci U S A,89,4207,4209,1349175,,
17,Splice-site mutation of the p53 gene in a family with hereditary breast-ovarian cancer,Jolly KW;Malkin D;Douglass EC;Brown TF;Sinclair AE;Look AT;,1994,Oncogene,9,97,102,8302608,,
18,p53 mosaicism with an exon 8 germline mutation in the founder of a cancer-prone pedigree,Kovar H;Auinger A;Jug G;Muller T;Pillwein K;,1992,Oncogene,7,2169,2173,1359493,,
19,Germline p53 gene mutations in subsets of glioma patients,Kyritsis AP;Bondy ML;Xiao M;Berman EL;Cunningham JE;Lee PS;Levin VA;Saya H;,1994,J Natl Cancer Inst,86,344,349,94141961,,
20,A germ line mutation in exon 5 of the p53 gene in an extended cancer family,Law JC;Strong LC;Chidambaram A;Ferrell RE;,1991,Cancer Res,51,6385,6387,1933902,,updated from Ref_ID 81
21,Familial brain tumour syndrome associated with a p53 germline deletion of codon 236,Lubbe J;von Ammon K;Watanabe K;Hegi ME;Kleihues P;,1995,Brain Pathol,5,15,23,7767487,,
22,"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms",Malkin D;Li FP;Strong LC;Fraumeni JF;Nelson CE;Kim DH;Kassel J;Gryka MA;Bischoff FZ;Tainsky MA;,1990,Science,250,1233,1238,1978757,,
23,Germline mutations of the p53 tumor-suppressor gene in children and young adults with second malignant neoplasms,Malkin D;Jolly KW;Barbier N;Look AT;Friend SH;Gebhardt MC;Andersen TI;Borresen AL;Li FP;Garber J;,1992,N Engl J Med,326,1309,1315,1565144,,
24,"Two germ-line mutations affecting the same nucleotide at codon 257 of p53 gene, a rare site for mutations",Mazoyer S;Lalle P;Moyret-Lalle C;Marcais C;Schraub S;Frappaz D;Sobol H;Ozturk M;,1994,Oncogene,9,1237,1239,8134127,,
25,Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma,McIntyre JF;Smith-Sorensen B;Friend SH;Kassell J;Borresen AL;Yan YX;Russo C;Sato J;Barbier N;Miser J;,1994,J Clin Oncol,12,925,930,8164043,,
26,Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma,Metzger AK;Sheffield VC;Duyk G;Daneshvar L;Edwards MS;Cogen PH;,1991,Proc Natl Acad Sci U S A,88,7825,7829,1679237,,
27,A germline 2.35 kb deletion of p53 genomic DNA creating a specific loss of the oligomerization domain inherited in a Li-Fraumeni syndrome family,Plummer SJ;Santibanez-Koref M;Kurosaki T;Liao S;Noble B;Fain PR;Anton-Culver H;Casey G;,1994,Oncogene,9,3273,3280,7936651,,
28,A significant proportion of patients with osteosarcoma may belong to Li- Fraumeni cancer families,Porter DE;Holden ST;Steel CM;Cohen BB;Wallace MR;Reid R;,1992,J Bone Joint Surg Br,74,883,886,1447251,,
29,Constitutional p53 mutation in a non-Li-Fraumeni cancer family,Prosser J;Porter D;Coles C;Condie A;Thompson AM;Chetty U;Steel CM;Evans HJ;,1992,Br J Cancer,65,527,528,1562462,,
31,Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma,Sameshima Y;Tsunematsu Y;Watanabe S;Tsukamoto T;Kawa-ha K;Hirata Y;Mizoguchi H;Sugimura T;Terada M;Yokota J;,1992,J Natl Cancer Inst,84,703,707,1569604,,
33,Hereditary p53 mutation in a patient with multiple tumors: significance for genetic counseling,Scott RJ;Krummenacher F;Mary JL;Weber W;Spycher M;Muller H;,1993,Schweiz Med Wochenschr,123,1287,1292,8393584,,
34,Germ-line p53 mutation is uncommon in patients with triple primary cancers,"Shiseki,M.; Nishikawa,R.; Yamamoto,H.; Ochiai,A.; Sugimura,H.; Shitara,N.; Sameshima,Y.; Mizoguchi,H.; Sugimura,T.; Yokota,J.",1993,Cancer Lett,73,51,57,8402598,,
35,Inherited p53 gene mutations in breast cancer,Sidransky D;Tokino T;Helzlsouer K;Zehnbauer B;Rausch G;Shelton B;Prestigiacomo L;Vogelstein B;Davidson N;,1992,Cancer Res,52,2984,2986,1581912,,
36,Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome,Srivastava S;Zou ZQ;Pirollo K;Blattner W;Chang EH;,1990,Nature,348,747,749,91080929,,
37,Germ-line exclusion of a single p53 allele by premature termination of translation in a Li-Fraumeni syndrome family,Stolzenberg MC;Brugieres L;Gardes M;Dessarps-Freichey F;Chompret A;Bressac B;Lenoir G;Bonaiti-Pellie C;Lemerle J;Feunteun J;,1994,Oncogene,9,2799,2804,8084585,,
38,Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma,Toguchida J;Yamaguchi T;Dayton SH;Beauchamp RL;Herrera GE;Ishizaki K;Yamamuro T;Meyers PA;Little JB;Sasaki MS;,1992,N Engl J Med,326,1301,1308,92228022,,Japan or USA; insC
38,Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma,Toguchida J;Yamaguchi T;Dayton SH;Beauchamp RL;Herrera GE;Ishizaki K;Yamamuro T;Meyers PA;Little JB;Sasaki MS;,1992,N Engl J Med,326,1301,1308,92228022,,Japan or USA
40,High frequency of germline p53 mutations in childhood adrenocortical cancer,Wagner J;Portwine C;Rabin K;Leclerc JM;Narod SA;Malkin D;,1994,J Natl Cancer Inst,86,1707,1710,7966399,,updated from ref 88
40,High frequency of germline p53 mutations in childhood adrenocortical cancer,Wagner J;Portwine C;Rabin K;Leclerc JM;Narod SA;Malkin D;,1994,J Natl Cancer Inst,86,1707,1710,7966399,,updated with ref_ID 319
40,High frequency of germline p53 mutations in childhood adrenocortical cancer,Wagner J;Portwine C;Rabin K;Leclerc JM;Narod SA;Malkin D;,1994,J Natl Cancer Inst,86,1707,1710,7966399,,
41,Germ-line splicing mutation of the p53 gene in a cancer-prone family,Warneford SG;Witton LJ;Townsend ML;Rowe PB;Reddel RR;Dalla-Pozza L;Symonds G;,1992,Cell Growth Differ,3,839,846,1467311,,
42,Rapid diagnosis of germline p53 mutation using the enzyme mismatch cleavage method,Giunta C;Youil R;Venter D;Chow CW;Somers G;Lafferty A;Kemper B;Cotton RG;,1996,Diagn Mol Pathol,5,265,270,8955618,,
43,A previously undescribed mutation within the tetramerisation domain of TP53 in a family with Li-Fraumeni syndrome,Varley JM;McGown G;Thorncroft M;Cochrane S;Morrison P;Woll P;Kelsey AM;Mitchell EL;Boyle J;Birch JM;Evans DG;,1996,Oncogene,12,2437,2442,8649785,,
44,"A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni- like syndrome, and LOH in a benign lesion from a mutation carrier",Varley JM;Thorncroft M;McGown G;Tricker K;Birch JM;Evans DG;,1996,Cancer Genet Cytogenet,90,14,16,8780740,,updated from ref 86
45,Complex replication error causes p53 mutation in a Li-Fraumeni family,Strauss EA;Hosler MR;Herzog P;Salhany K;Louie R;Felix CA;,1995,Cancer Res,55,3237,3241,7614454,,insTGGTTG
46,Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome,Shay JW;Tomlinson G;Piatyszek MA;Gollahon LS;,1995,Mol Cell Biol,15,425,432,7799951,,
47,A novel p53 germline alteration identified in a late onset breast cancer kindred,"Sun,X.F.; Johannsson,O.; Hakansson,S.; Sellberg,G.; Nordenskjold,B.; Olsson,H.; Borg,A.",1996,Oncogene,13,407,411,8710380,,
48,A constitutional de novo mutation in exon 8 of the p53 gene in a patient with multiple primary malignancies,Speiser P;Gharehbaghi-Schnell E;Eder S;Haid A;Kovarik J;Nenutil R;Sauter G;Schneeberger CH;Vojtesek B;Wiltschke CH;Zeillinger R;,1996,Br J Cancer,74,269,273,8688334,,
49,Constitutional p53 mutations associated with brain tumors in young adults,Chen P;Iavarone A;Fick J;Edwards M;Prados M;Israel MA;,1995,Cancer Genet Cytogenet,82,106,115,7664239,,
50,Three germline mutations in the TP53 gene,Cornelis RS;van Vliet M;van de Vijver MJ;Vasen HF;Voute PA;Top B;Khan PM;Devilee P;Cornelisse CJ;,1997,Hum Mutat,9,157,163,9067756,,
51,p53 gene mutations and protein accumulation in human ovarian cancer,Kupryjanczyk J;Thor AD;Beauchamp R;Merritt V;Edgerton SM;Bell DA;Yandell DW;,1993,Proc Natl Acad Sci U S A,90,4961,4965,8506342,,
52,Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family,Lomax ME;Barnes DM;Gilchrist R;Picksley SM;Varley JM;Camplejohn RS;,1997,Oncogene,14,1869,1874,9150393,,Family tree in Lancet 1992
53,The p53 gene in pediatric therapy-related leukemia and myelodysplasia,Felix CA;Hosler MR;Provisor D;Salhany K;Sexsmith EA;Slater DJ;Cheung NK;Winick NJ;Strauss EA;Heyn R;Lange BJ;Malkin D;,1996,Blood,87,4376,4381,8639798,,
54,Incidence of germ-line p53 mutations in patients with gliomas,Li YJ;Sanson M;Hoang-Xuan K;Delattre JY;Poisson M;Thomas G;Hamelin R;,1995,Int J Cancer,64,383,387,8550239,,
55,Germline p53 mutation at codon 133 in a cancer-prone family,Saeki Y;Tamura K;Yamamoto Y;Hatada T;Furuyama J;Utsunomiya J;,1997,J Mol Med,75,50,56,9020384,,
56,Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours,"Sedlacek,Z.; Kodet,R.; Seemanova,E.; Vodvarka,P.; Wilgenbus,P.; Mares,J.; Poustka,A.; Goetz,P.",1998,Br J Cancer,77,1034,1039,9569035,,
57,DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation,Goi K;Takagi M;Iwata S;Delia D;Asada M;Donghi R;Tsunematsu Y;Nakazawa S;Yamamoto H;Yokota J;Tamura K;Saeki Y;Utsunomiya J;Takahashi T;Ueda R;Ishioka C;Eguchi M;Kamata N;Mizutani S;,1997,Cancer Res,57,1895,1902,9157982,"2 families reported in ref 33,15",
58,The first documentation of Li-Fraumeni syndrome in Korea,Bang YJ;Kang SH;Kim TY;Jung CW;Oh SM;Choe KJ;Kim NK;,1995,J Korean Med Sci,10,205,210,8527048,,
59,Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining,MacGeoch C;Turner G;Bobrow LG;Barnes DM;Bishop DT;Spurr NK;,1995,J Med Genet,32,186,190,7783166,"DNA, direct, ex5-9",
60,A novel germ line p53 mutation in intron 6 in diverse childhood malignancies,Avigad S;Barel D;Blau O;Malka A;Zoldan M;Mor C;Fogel M;Cohen IJ;Stark B;Goshen Y;Stein J;Zaizov R;,1997,Oncogene,14,1541,1545,9129144,,
61,p53 gene mutations in pediatric brain tumors,Felix CA;Slavc I;Dunn M;Strauss EA;Phillips PC;Rorke LB;Sutton L;Bunin GR;Biegel JA;,1995,Med Pediatr Oncol,25,431,436,7565304,,
62,P53 germline mutations in childhood cancers and cancer risk for carrier individuals,Chompret A;Brugieres L;Ronsin M;Gardes M;Dessarps-Freichey F;Abel A;Hua D;Ligot L;Dondon MG;Bressac-de Paillerets B;Frebourg T;Lemerle J;Bonaiti-Pellie C;Feunteun J;,2000,Br J Cancer,82,1932,1937,10864200,,
62,P53 germline mutations in childhood cancers and cancer risk for carrier individuals,Chompret A;Brugieres L;Ronsin M;Gardes M;Dessarps-Freichey F;Abel A;Hua D;Ligot L;Dondon MG;Bressac-de Paillerets B;Frebourg T;Lemerle J;Bonaiti-Pellie C;Feunteun J;,2000,Br J Cancer,82,1932,1937,10864200,,updated with RefID-449
63,TP53 gene mutations and 17p deletions in human astrocytomas,Chung R;Whaley J;Kley N;Anderson K;Louis D;Menon A;Hettlich C;Freiman R;Hedley-Whyte ET;Martuza R;,1991,Genes Chromosomes Cancer,3,323,331,1686725,,
65,A new germline TP53 gene mutation in a family with Li-Fraumeni syndrome,Dockhorn-Dworniczak B;Wolff J;Poremba C;Schafer KL;Ritter J;Gullotta F;Jurgens H;Bocker W;,1996,Eur J Cancer,,1359,1365,8869100,,
66,Molecular pathology in basal cell cancer with p53 as a genetic marker,Ponten F;Berg C;Ahmadian A;Ren ZP;Nister M;Lundeberg J;Uhlen M;Ponten J;,1997,Oncogene,15,1059,1067,9285560,,
67,Primitive neuroectodermal tumors of the cerebral hemispheres in two siblings with TP53 germline mutation,Reifenberger J;Janssen G;Weber RG;Bostrom J;Engelbrecht V;Lichter P;Borchard F;Gobel U;Lenard HG;Reifenberger G;,1998,J Neuropathol Exp Neurol,57,179,187,9600210,,mutant codon 213 is TGG(W) due to polymorphism
68,Are There Low-Penetrance TP53 Alleles? Evidence from Childhood Adrenocortical Tumors,Varley JM;McGown G;Thorncroft M;James LA;Margison GP;Forster G;Evans DG;Harris M;Kelsey AM;Birch JM;,1999,Am J Hum Genet,65,995,1006,10486318,,
69,Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation,Pivnick EK;Furman WL;Velagaleti GV;Jenkins JJ;Chase NA;Ribeiro RC;,1998,J Med Genet,35,328,332,9598730,,
70,A germline missense mutation R337C in exon 10 of the human p53 gene,Luca JW;Strong LC;Hansen MF;,1998,Hum Mutat,1,58,61,9452042,,
71,Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemia,Felix CA;Megonigal MD;Chervinsky DS;Leonard DG;Tsuchida N;Kakati S;Block AM;Fisher J;Grossi M;Salhany KI;Jani-Sait SN;Aplan PD;,1998,Blood,91,4451,4456,9616138,,
72,A novel TP53 germ-line mutation identified in a girl with a primitive neuroectodermal tumor and her father,Orellana C;Martinez F;Hernandez-Marti M;Castel V;Canete A;Prieto F;Badia L;,1998,Cancer Genet Cytogenet,105,103,108,9723024,,
73,Astrocytomas and choroid plexus tumors in two families with identical p53 germline mutations,Vital A;Bringuier PP;Huang H;San Galli F;Rivel J;Ansoborlo S;Cazauran JM;Taillandier L;Kleihues P;Ohgaki H;,1998,J Neuropathol Exp Neurol,57,1061,1069,9825943,,
74,Astrocytoma and B-cell lymphoma development in a man with a p53 germline mutation,Murakawa Y;Yokoyama A;Kato S;Yoshioka T;Ichinohasama R;Kumabe T;Yoshimoto T;Ishioka C;Kanamaru R;,1998,Jpn J Clin Oncol,28,631,637,9839505,,
75,Germline mutations of the p53 gene in children with malignant solid tumors,Ayan I;Luca JW;Jaffe N;Yazici H;Ekmekcioglu S;Hansen MF;,1998,J Exp Clin Cancer Res,17,497,502,10089074,,
76,Molecular assessment of clonality leads to the identification of a new germ line TP53 mutation associated with malignant cystosarcoma phyllodes and soft tissue sarcoma,Bot FJ;Sleddens HF;Dinjens WN;,1998,Diagn Mol Pathol,7,295,301,10207667,,
77,A novel germ-line mutation in the noncoding region of the p53 gene in a Li-Fraumeni family,Barel D;Avigad S;Mor C;Fogel M;Cohen IJ;Zaizov R;,1998,Cancer Genet Cytogenet,103,1,6,9595036,,CCGGGTGA>CCAGGTTGGA
78,Multiple primary tumors of the upper aerodigestive tract: is there a role for constitutional mutations in the p53 gene?,Gallo O;Sardi I;Pepe G;Franchi A;Attanasio M;Giusti B;Bocciolini C;Abbate R;,1999,Int J Cancer,82,180,186,10389749,,
79,Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2,Huusko P;Castren K;Launonen V;Soini Y;Paakkonen K;Leisti J;Vahakangas K;Winqvist R;,1999,Cancer Genet Cytogenet,112,9,14,10432928,,
80,Variations of p53 in cultured fibroblasts of patients with lung cancer who have a presumed genetic predisposition,Auer H;Warncke K;Nowak D;Koops F;Jaeger U;Kurzbauer R;Ruediger HW;,1999,Am J Clin Oncol,22,278,282,10362336,,
81,TP53 mutation and haplotype analysis of two large African American families,Hung J;Mims B;Lozano G;Strong L;Harvey C;Chen TT;Stastny V;Tomlinson G;,1999,Hum Mutat,14,216,221,10477429,,
82,p53 compound heterozygosity in a severely affected child with Li-Fraumeni syndrome,Quesnel S;Verselis S;Portwine C;Garber J;White M;Feunteun J;Malkin D;Li FP;,1999,Oncogene,18,3970,3978,99361973,,
83,Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Francaise,Zhou XP;Sanson M;Hoang-Xuan K;Robin E;Taillandier L;He J;Mokhtari K;Cornu P;Delattre JY;Thomas G;Hamelin R;,1999,Ann Neurol,46,913,916,10589545,,
84,Germline p53 mutation in a case of Li-Fraumeni syndrome presenting gastric cancer,Sugano K;Taniguchi T;Saeki M;Tsunematsu Y;Tomaru U;Shimoda T;,1999,Jpn J Clin Oncol,29,513,516,10645809,,
86,Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families,Varley JM;McGown G;Thorncroft M;Santibanez-Koref MF;Kelsey AM;Tricker KJ;Evans DG;Birch JM;,1997,Cancer Res,57,3245,3252,9242456,"DNA, direct, ex4-9(all?)",
86,Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families,Varley JM;McGown G;Thorncroft M;Santibanez-Koref MF;Kelsey AM;Tricker KJ;Evans DG;Birch JM;,1997,Cancer Res,57,3245,3252,9242456,"DNA, direct, ex4-9(all?)",Updated with Ref-174
86,Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families,Varley JM;McGown G;Thorncroft M;Santibanez-Koref MF;Kelsey AM;Tricker KJ;Evans DG;Birch JM;,1997,Cancer Res,57,3245,3252,9242456,"DNA, direct, ex4-9(all?)",Updated with ref 89
86,Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families,Varley JM;McGown G;Thorncroft M;Santibanez-Koref MF;Kelsey AM;Tricker KJ;Evans DG;Birch JM;,1997,Cancer Res,57,3245,3252,9242456,"DNA, direct, ex4-9(all?)",updated with ref 87
90,"Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma",Tachibana I;Smith JS;Sato K;Hosek SM;Kimmel DW;Jenkins RB;,2000,Am J Med Genet,92,136,141,10797439,,
91,Personnal communication,Eeles RA;,2000,Unpublished,,,,NA,,
93,Two cases of osteosarcoma occurring as second malignancy of childhood cancer,Yonemoto T;Tatezaki S;Ishii T;Satoh T;Inoue M;,1999,Anticancer Res,19,5563,5565,10697617,,
94,High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer,Grzybowska E;Zientek H;Jasinska A;Rusin M;Kozlowski P;Sobczak K;Sikorska A;Kwiatkowska E;Gorniak L;Kalinowska E;Utracka-Hutka B;Wloch J;Chmielik E;Krzyzosiak WJ;,2000,Hum Mutat,16,482,490,11102977,,
97,Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites,Rapakko K;Allinen M;Syrjakoski K;Vahteristo P;Huusko P;Vahakangas K;Eerola H;Kainu T;Kallioniemi OP;Nevanlinna H;Winqvist R;,2001,Br J Cancer,84,116,119,11139324,,
98,Novel p53 splice site mutations in three families with Li-Fraumeni syndrome,Verselis SJ;Rheinwald JG;Fraumeni JF;Li FP;,2000,Oncogene,19,4230,4235,10980596,,
98,Novel p53 splice site mutations in three families with Li-Fraumeni syndrome,Verselis SJ;Rheinwald JG;Fraumeni JF;Li FP;,2000,Oncogene,19,4230,4235,10980596,,can't identify proband
99,Detection of 11 germline inactivating TP53 mutations and absence of TP63 and HCHK2 mutations in 17 French families with Li-Fraumeni or Li-Fraumeni-like syndrome,Bougeard G;Limacher JM;Martin C;Charbonnier F;Killian A;Delattre O;Longy M;Jonveaux P;Fricker JP;Stoppa-Lyonnet D;Flaman JM;Frebourg T;,2001,J Med Genet,38,253,257,11370630,,
100,Germline p53 mutation in a patient with multiple primary cancers,Kimura K;Shinmura K;Hasegawa T;Beppu Y;Yokoyama R;Yokota J;,2001,Jpn J Clin Oncol,31,349,351,11518751,,
101,Tissue-specific expression of SV40 in tumors associated with the Li- Fraumeni syndrome,Malkin D;Chilton-MacNeill S;Meister LA;Sexsmith E;Diller L;Garcea RL;,2001,Oncogene,20,4441,4449,11494139,,
102,A double germline mutations in the APC and p53 genes,Zajac V;Tomka M;Ilencikova D;Majek P;Stevurkova V;Kirchhoff T;,2000,Neoplasma,47,335,341,11263856,,FAP
103,"p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition",Vahteristo P;Tamminen A;Karvinen P;Eerola H;Eklund C;Aaltonen LA;Blomqvist C;Aittomaki K;Nevanlinna H;,2001,Cancer Res,61,5718,5722,11479205,,
104,"Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas",Joachim T;Ram Z;Rappaport ZH;Simon M;Schramm J;Wiestler OD;von Deimling A;,2001,Int J Cancer,94,218,221,11668501,,
105,"A novel, de novo germline TP53 mutation in a rare presentation of the Li-Fraumeni syndrome in the maxilla",Patrikidou A;Bennett J;Abou-Sleiman P;Delhanty JD;Harris M;,2002,Oral Oncol,38,383,390,12076704,,
106,Investigations on a clinically and functionally unusual and novel germline p53 mutation,Rutherford J;Chu CE;Duddy PM;Charlton RS;Chumas P;Taylor GR;Lu X;Barnes DM;Camplejohn RS;,2002,Br J Cancer,86,1592,1596,12085209,,insGCCATGG
108,p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies,Potzsch C;Voigtlander T;Lubbert M;,2002,J Cancer Res Clin.Oncol,128,456,460,12200603,,
109,Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?,Martin AM;Kanetsky PA;Amirimani B;Colligon TA;Athanasiadis G;Shih HA;Gerrero MR;Calzone K;Rebbeck TR;Weber BL;,2003,J Med Genet,40,,,12676907,,
110,Prediction of pathogenic mutations in patients with early-onset breast cancer by family history,Lalloo F;Varley J;Ellis D;Moran A;O'Dair L;Pharoah P;Evans DG;,2003,Lancet,361,1101,1102,12672316,,
111,Novel p53 germline mutation in a patient with Li-Fraumeni syndrome,Wong SS;Lozano G;Gaff CL;Gardner RJ;Strong LC;Aittomaki K;Lindeman GJ;,2003,Intern Med J,33,621,,14656244,,
112,Description of a new TP53 gene germline mutation in a family with the Li-Fraumeni syndrome. Genetic counselling to healthy mutation carriers,Balmana J;Nomdedeu J;Diez O;Sabate JM;Balil A;Pericay C;Lopez Lopez JJ;Brunet J;Baiget M;Alonso C;,2002,Med Clin (Barc),119,497,499,12406399,,
113,Screening for TP53 rearrangements in families with the Li-Fraumeni syndrome reveals a complete deletion of the TP53 gene,Bougeard G;Brugieres L;Chompret A;Gesta P;Charbonnier F;Valent A;Martin C;Raux G;Feunteun J;Bressac-de Paillerets B;Frebourg T;,2003,Oncogene,22,840,846,12584563,,
115,A novel case with germline p53 gene mutation having concurrent multiple primary colon tumours,Miyaki M;Iijima T;Ohue M;Kita Y;Hishima T;Kuroki T;Iwama T;Mori T;,2003,Gut,52,304,306,12524418,,
116,A Li-Fraumeni syndrome family with retained heterozygosity for a germline TP53 mutation in two tumors,Trkova M;Foretova L;Kodet R;Hedvicakova P;Sedlacek Z;,2003,Cancer Genet Cytogenet,145,60,64,12885464,,
117,Familial sarcoma: challenging pedigrees,Lynch HT;Deters CA;Hogg D;Lynch JF;Kinarsky Y;Gatalica Z;,2003,Cancer,98,1947,1957,14584079,,
118,An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma,Ribeiro RC;Sandrini F;Figueiredo B;Zambetti GP;Michalkiewicz E;Lafferty AR;DeLacerda L;Rabin M;Cadwell C;Sampaio G;Cat I;Stratakis CA;Sandrini R;,2001,Proc Natl Acad Sci U S A,98,9330,9335,11481490,,
119,Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor,Ishii N;Tada M;Hamou MF;Janzer RC;Meagher-Villemure K;Wiestler OD;Tribolet N;Van Meir EG;,1999,Oncogene,18,5870,5878,10557074,,
120,Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family,Guran S;Tunca Y;Imirzalioglu N;,1999,Cancer Genet Cytogenet,113,145,151,10484981,,
121,An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors,Latronico AC;Pinto EM;Domenice S;Fragoso MC;Martin RM;Zerbini MC;Lucon AM;Mendonca BB;,2001,J Clin Endocrinol Metab,86,4970,4973,11600572,,
122,Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray-based sequencing technology,Schaefer KL;Wai D;Poremba C;Diallo R;Boecker W;Dockhorn-Dworniczak B;,2002,Med Pediatr Oncol,38,247,253,11920788,,
123,"Leukemic and non-leukemic lymphocytes from patients with Li Fraumeni syndrome demonstrate loss of p53 function, Bcl-2 family dysregulation and intrinsic resistance to conventional chemotherapeutic drugs but not flavopiridol",Pepper C;Thomas A;Hoy T;Tighe J;Culligan D;Fegan C;Bentley P;,2003,Cell Cycle,2,53,58,12695689,,
125,"TP53, BRCA1, and BRCA2 Tumor Suppressor Genes Are Not Commonly Mutated in Survivors of Hodgkin's Disease With Second Primary Neoplasms",Nichols KE;Heath JA;Friedman D;Biegel JA;Ganguly A;Mauch P;Diller L;,2003,J Clin Oncol,21,4505,4509,14673037,,
126,Prenatal diagnosis in Li-Fraumeni syndrome,Avigad S;Peleg D;Barel D;Benyaminy H;Ben Baruch N;Taub E;Shohat M;Goshen Y;Cohen IJ;Yaniv I;Zaizov R;,2004,J Pediatr Hematol Oncol,26,541,545,15342977,,
127,"Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India",Hedau S;Jain N;Husain SA;Mandal AK;Ray G;Shahid M;Kant R;Gupta V;Shukla NK;Deo SS;Das BC;,2004,Breast Cancer Res Treat,88,177,186,15564800,,
128,"Rhabdomyosarcoma, osteosarcoma, and adrenocortical carcinoma in a child with a germline p53 mutation",Khayat CM;Johnston DL;,2004,Pediatr Blood Cancer,43,683,686,15390294,,
129,Genetic and epigenetic alterations of the cell cycle regulators and tumor suppressor genes in pediatric osteosarcomas,Patino-Garcia A;Pineiro ES;Diez MZ;Iturriagagoitia LG;Klussmann FA;Ariznabarreta LS;,2003,J Pediatr Hematol Oncol,25,362,367,12759621,,
130,A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome,Kim IJ;Kang HC;Shin Y;Park HW;Jang SG;Han SY;Lim SK;Lee MR;Chang HJ;Ku JL;Yang HK;Park JG;,2004,J Hum Genet,49,591,595,15368100,,
131,Multifocal intrafollicular granulosa cell tumor of the ovary associated with an unusual germline p53 mutation,Nogales FF;Musto ML;Saez AI;Robledo M;Palacios J;Aneiros J;,2004,Mod Pathol,17,868,873,15073606,,
132,Multiple primary cancers in patients with osteosarcoma: influence of anticancer drugs and genetic factors,Yonemoto T;Tatezaki S;Ishii T;Hagiwara Y;Inoue M;,2004,Am J Clin Oncol,27,220,224,15170137,,
133,Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin,Bendig I;Mohr N;Kramer F;Weber BH;,2004,Cancer Genet Cytogenet,154,22,26,15381368,,
133,Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin,Bendig I;Mohr N;Kramer F;Weber BH;,2004,Cancer Genet Cytogenet,154,22,26,15381368,,insCCCC
134,Personnal communication,Sarin R;,2004,Unpublished,,,,NA,,
135,Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk,Hwang SJ;Lozano G;Amos CI;Strong LC;,2003,Am J Hum Genet,72,975,983,12610779,,incomplete data
136,E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients,Oliveira C;Ferreira P;Nabais S;Campos L;Ferreira A;Cirnes L;Alves CC;Veiga I;Fragoso M;Regateiro F;Dias LM;Moreira H;Suriano G;Machado JC;Lopes C;Castedo S;Carneiro F;Seruca R;,2004,Eur J Cancer,40,1897,1903,15288293,,
137,Second malignant neoplasms in childhood acute lymphoblastic leukemia: primitive neuroectodermal tumor of the chest wall with germline p53 mutation as a second malignant neoplasm,Suarez CR;Bertolone SJ;Raj AB;Coventry S;,2004,Am J Hematol,76,52,56,15114597,,
138,"The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families",Achatz MI;Olivier M;Calvez FL;Martel-Planche G;Lopes A;Rossi BM;Ashton-Prolla P;Giugliani R;Palmero EI;Vargas FR;Rocha JC;Vettore AL;Hainaut P;,2007,Cancer Lett,245,96,102,16494995,corrections after MLPA analysis,
139,CGH evalution of two de novo synchronous tumors in a child with a germline p53 mutation,Roque L;Lacerda A;Rodrigues R;Almeida O;Salgueiro J;Pinto C;,2005,Pediatr Blood Cancer,47,949,54,16206219,,
140,"Germline mutations of the E-cadherin(CDH1) and TP53 genes, rather than of RUNX3 and HPP1, contribute to genetic predisposition in German gastric cancer patients",Keller G;Vogelsang H;Becker I;Plaschke S;Ott K;Suriano G;Mateus AR;Seruca R;Biedermann K;Huntsman D;Doring C;Holinski-Feder E;Neutzling A;Siewert JR;Hofler H;,2004,J Med Genet,41,,,15173255,,
141,Identification of five new families strengthens the link between childhood choroid plexus carcinoma and germline TP53 mutations,Krutilkova V;Trkova M;Fleitz J;Gregor V;Novotna K;Krepelova A;Sumerauer D;Kodet R;Siruckova S;Plevova P;Bendova S;Hedvicakova P;Foreman NK;Sedlacek Z;,2005,Eur J Cancer,41,1597,1603,15925506,,
142,Malignant triton tumor in a patient with Li-Fraumeni syndrome and a novel TP53 mutation,Chao MM;Levine JE;Ruiz RE;Kohlmann WK;Bower MA;Petty EM;Mody RJ;,2005,Pediatr Blood Cancer,,,,16333835,,
143,Hereditary breast cancer syndromes in a Turkish population. Results of molecular germline analysis,Guran S;Ozet A;Dede M;Gille JJ;Yenen MC;,2005,Cancer Genet Cytogenet,160,164,168,15993273,,
144,A patient with TP53 germline mutation developed Bowen's disease and myelodysplastic syndrome with myelofibrosis after chemotherapy against ovarian cancer,Kuribayashi K;Matsunaga T;Sakai T;Wada Y;Tateno K;Murase K;Fujimi A;Takimoto R;Terui T;Kato J;Sasaki A;Satoh M;Niitsu Y;,2005,Intern Med,44,490,495,15942101,,
145,Atypical molecular background of glioblastoma and meningioma developed in a patient with Li-Fraumeni syndrome,Rieske P;Zakrzewska M;Biernat W;Bartkowiak J;Zimmermann A;Liberski PP;,2005,J Neurooncol,71,27,30,15719270,,
146,Germline p53 mutation presenting as synchronous tumors,Cavalier ME;Davis MM;Croop JM;,2005,J Pediatr Hematol Oncol,27,441,443,16096528,,
147,Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation,Capponcelli S;Pedrini E;Cerone MA;Corti V;Fontanesi S;Alessio M;Bachi A;Soddu S;Ribatti D;Picci P;Helman LJ;Cantelli-Forti G;Sangiorgi L;,2005,Hum Mutat,26,94,103,15977174,,
148,Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome,Wong P;Verselis SJ;Garber JE;Schneider K;DiGianni L;Stockwell DH;Li FP;Syngal S;,2006,Gastroenterology,130,73,79,16401470,,
149,Inheritance of R337H p53 gene mutation in children with sporadic adrenocortical tumor,Sandrini F;Villani DP;Tucci S;Moreira AC;de Castro M;Elias LL;,2005,Horm Metab Res,37,231,235,15952083,,
150,Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation,Figueiredo BC;Sandrini R;Zambetti GP;Pereira RM;Cheng C;Liu W;Lacerda L;Pianovski MA;Michalkiewicz E;Jenkins J;Rodriguez-Galindo C;Mastellaro MJ;Vianna S;Watanabe F;Sandrini F;Arram SB;Boffetta P;Ribeiro RC;,2006,J Med Genet,43,91,96,16033918,,no accurate pedigree
151,Successful treatment of an unresectable choroid plexus carcinoma in a patient with Li-Fraumeni syndrome,Dickens DS;Dothage JA;Heideman RL;Ballard ET;Jubinsky PT;,2005,J Pediatr Hematol Oncol,27,46,49,15654279,,
152,Germline p53 single-base changes associated with Balkan endemic nephropathy,Krasteva ME;Georgieva EI;,2006,Biochem Biophys Res Commun,342,562,567,16487937,,
153,The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds,Siddiqui R;Onel K;Facio F;Nafa K;Diaz LR;Kauff N;Huang H;Robson M;Ellis N;Offit K;,2005,Fam Cancer,4,177,181,15951970,,
154,Fibroadenoma with atypical giant cells occurring in Li Fraumeni Syndrome,Parham DM;Eccles DM;,2001,Breast,10,330,332,14965603,,
155,"Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer",Walsh T;Casadei S;Coats KH;Swisher E;Stray SM;Higgins J;Roach KC;Mandell J;Lee MK;Ciernikova S;Foretova L;Soucek P;King MC;,2006,JAMA,295,1379,1388,16551709,,
156,Primary orbital liposarcoma in Li-Fraumeni cancer family syndrome: a case report,Poli T;Lagana F;Caradonna L;Gobbi R;Corradi D;Sesenna E;,2005,Tumori,91,96,100,15850016,,
157,Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families,Manoukian S;Peissel B;Pensotti V;Barile M;Cortesi L;Stacchiotti S;Terenziani M;Barbera F;Pasquini G;Frigerio S;Pierotti MA;Radice P;Della-Torre G;,2007,Eur J Cancer,43,601,606,17224268,,insG
157,Germline mutations of TP53 and BRCA2 genes in breast cancer/sarcoma families,Manoukian S;Peissel B;Pensotti V;Barile M;Cortesi L;Stacchiotti S;Terenziani M;Barbera F;Pasquini G;Frigerio S;Pierotti MA;Radice P;Della-Torre G;,2007,Eur J Cancer,43,601,606,17224268,,
158,Late-onset common cancers in a kindred with an Arg213Gln TP53 germline mutation,Ruijs MW;Verhoef S;Wigbout G;Pruntel R;Floore AN;de Jong D;van T;Menko FH;,2006,Fam Cancer,5,169,174,16736287,,
159,Identification of a novel germ line variant hotspot mutant p53-R175L in pediatric adrenal cortical carcinoma,West AN;Ribeiro RC;Jenkins J;Rodriguez-Galindo C;Figueiredo BC;Kriwacki R;Zambetti GP;,2006,Cancer Res,66,5056,5062,16707427,,
160,A novel splice mutation in the TP53 gene associated with Leydig cell tumor and primitive neuroectodermal tumor,Stecher CW;Gronbaek K;Hasle H;,2006,Pediatr Blood Cancer,,,,17066464,,
161,A chronic myeloid leukemia-like syndrome case with del (12) (p12) in a Li-Fraumeni syndrome family,Guran S;Beyan C;Nevruz O;Yakicier C;Tunca Y;,2005,Clin Lab Haematol,27,135,138,15784129,,
162,"Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report",Anensen N;Skavland J;Stapnes C;Ryningen A;Borresen-Dale AL;Gjertsen BT;Bruserud O;,2006,Leukemia,20,734,736,16437140,,
163,The first case of Li-Fraumeni syndrome in Bosnia and Herzegovina: case report,Vranic S;Kapur L;Foco F;Bilalovic N;Hainaut P;,2006,Pathologica,98,156,159,16929790,,
164,"BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma",Monnerat C;Chompret A;Kannengiesser C;Avril MF;Janin N;Spatz A;Guinebretiere JM;Marian C;Barrois M;Boitier F;Lenoir GM;Bressac-de Paillerets B;,2007,Fam Cancer,,,,17624602,,
165,Two TP53 germline mutations in a classical Li-Fraumeni syndrome family,van Hest LP;Ruijs MW;Wagner A;van der Meer CA;Verhoef S;Van't Veer LJ;Meijers-Heijboer H;,2007,Fam Cancer,6,311,316,17318340,,
166,Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families,Arcand SL;Maugard CM;Ghadirian P;Robidoux A;Perret C;Zhang P;Fafard E;Mes-Masson AM;Foulkes WD;Provencher D;Narod SA;Tonin PN;,2008,Breast Cancer Res Treat,108,399,408,17541742,,related to family 1039 (see ref_ID 319)
166,Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families,Arcand SL;Maugard CM;Ghadirian P;Robidoux A;Perret C;Zhang P;Fafard E;Mes-Masson AM;Foulkes WD;Provencher D;Narod SA;Tonin PN;,2008,Breast Cancer Res Treat,108,399,408,17541742,,related to family 1444 (see ref_ID 319)
166,Germline TP53 mutations in BRCA1 and BRCA2 mutation-negative French Canadian breast cancer families,Arcand SL;Maugard CM;Ghadirian P;Robidoux A;Perret C;Zhang P;Fafard E;Mes-Masson AM;Foulkes WD;Provencher D;Narod SA;Tonin PN;,2008,Breast Cancer Res Treat,108,399,408,17541742,,
167,Rapid Development of Post-radiotherapy Sarcoma and Breast Cancer in a Patient with a Novel Germline 'De-Novo'TP53 Mutation,Salmon A;Amikam D;Sodha N;Davidson S;Basel-Vanagaite L;Eeles RA;Abeliovich D;Peretz T;,2007,Clin Oncol (R Coll Radiol ),19,490,493,17572079,,
168,Recognition of Li Fraumeni syndrome at diagnosis of a locally advanced extremity rhabdomyosarcoma,Trahair T;Andrews L;Cohn RJ;,2007,Pediatr Blood Cancer,48,345,348,16534790,,
169,Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family,Schiffman JD;Chun N;Fisher PG;Dahl GV;Ford JM;Eggerding FA;,2007,Pediatr Blood Cancer,,,,17554785,,
170,[Germline tp53 neomutation in a patient with li-fraumeni syndrome and pancreatic adenocarcinoma],Lefrou L;Godart B;de Muret A;Scotto B;Dorval E;,2006,Gastroenterol Clin Biol,30,484,486,16633321,,
171,p53 therapy in a patient with Li-Fraumeni syndrome,Senzer N;Nemunaitis J;Nemunaitis M;Lamont J;Gore M;Gabra H;Eeles R;Sodha N;Lynch FJ;Zumstein LA;Menander KB;Sobol RE;Chada S;,2007,Mol Cancer Ther,6,1478,1482,17483435,,
172,Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation,Rossbach HC;Baschinsky D;Wynn T;Obzut D;Sutcliffe M;Tebbi C;,2007,Pediatr Blood Cancer,,,,17427234,,
173,EGFR-mutant lung adenocarcinoma in a patient with Li-Fraumeni syndrome,Bemis LT;Robinson WA;McFarlane R;Buyers E;Kelly K;Varella-Garcia M;Mitchell JD;Franklin WA;,2007,Lancet Oncol,8,559,560,17540308,,
174,Characterization of germline TP53 splicing mutations and their genetic and functional analysis,"Varley,J.M.; Attwooll,C.; White,G.; McGown,G.; Thorncroft,M.; Kelsey,A.M.; Greaves,M.; Boyle,J.; Birch,J.M.",2001,Oncogene,20,2647,2654,11420676,,
175,Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas,Idbaih A;Boisselier B;Sanson M;Criniere E;Liva S;Marie Y;Carpentier C;Paris S;Laigle-Donadey F;Mokhtari K;Kujas M;Hoang-Xuan K;Delattre O;Delattre JY;,2007,Cancer Genet Cytogenet,176,121,126,17656254,,
176,A rare tumor and an ethical dilemma in a family with a germline TP53 mutation,Prochazkova K;Foretova L;Sedlacek Z;,2008,Cancer Genet Cytogenet,180,65,69,18068537,,
177,Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome,Tabori U;Nanda S;Druker H;Lees J;Malkin D;,2007,Cancer Res,67,1415,1418,17308077,Add info sent by Malkin,
177,Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome,Tabori U;Nanda S;Druker H;Lees J;Malkin D;,2007,Cancer Res,67,1415,1418,17308077,Add info sent by Malkin,insC
178,Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age,Trkova M;Prochazkova K;Krutilkova V;Sumerauer D;Sedlacek Z;,2007,Cancer,110,694,702,17567834,,
179,Identification and characterization of a novel germ line p53 mutation in familial gastric cancer in the Japanese population,Yamada H;Shinmura K;Okudela K;Goto M;Suzuki M;Kuriki K;Tsuneyoshi T;Sugimura H;,2007,Carcinogenesis,28,2013,2018,17690113,,Familial gastric cancer
180,A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene,Izawa N;Matsumoto S;Manabe J;Tanizawa T;Hoshi M;Shigemitsu T;Machinami R;Kanda H;Takeuchi K;Miki Y;Arai M;Shirahama S;Kawaguchi N;,2008,Int J Clin Oncol,13,78,82,18307025,,
181,Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma,Russell-Swetek A;West AN;Mintern JE;Jenkins J;Rodriguez-Galindo C;Ribeiro R;Zambetti GP;,2008,J Med Genet,45,603,606,18762572,,
182,High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability,Veschi S;Aceto G;Scioletti AP;Gatta V;Palka G;Cama A;Mariani-Costantini R;Battista P;Calo V;Barbera F;Bazan V;Russo A;Stuppia L;,2007,Ann Oncol,18,,,17591842,,
183,"Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil",Palmero EI;Schuler-Faccini L;Caleffi M;Achatz MI;Olivier M;Martel-Planche G;Marcel V;Aguiar E;Giacomazzi J;Ewald IP;Giugliani R;Hainaut P;shton-Prolla P;,2008,Cancer Lett,261,21,25,18248785,,
184,Li-Fraumeni syndrome in a Malaysian kindred,Ariffin H;Martel-Planche G;Daud SS;Ibrahim K;Hainaut P;,2008,Cancer Genet Cytogenet,186,49,53,18786442,Updated with ref-238,insGGCGTG; add info from ref-238
185,Association of the germline TP53 R337H mutation with breast cancer in southern Brazil,Assumpcao JG;Seidinger AL;Mastellaro MJ;Ribeiro RC;Zambetti GP;Ganti R;Srivastava K;Shurtleff S;Pei D;Zeferino LC;Dufloth RM;Brandalise SR;Yunes JA;,2008,BMC Cancer,8,357,,19046423,,
186,Choroid plexus carcinoma: a new case associated with a novel TP53 germ line mutation,Becherini F;Castagna M;Iannelli A;Favre C;Abbruzzese A;Caligo MA;Bertacca G;Pingitore R;Bevilacqua G;Cavazzana AO;,2008,Neuropathol Appl Neurobiol,34,564,568,18208484,,
187,Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families,Bougeard G;Sesboue R;Baert-Desurmont S;Vasseur S;Martin C;Tinat J;Brugieres L;Chompret A;de Paillerets BB;Stoppa-Lyonnet D;Bonaiti-Pellie C;Frebourg T;,2008,J Med Genet,45,535,538,18511570,,
187,Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families,Bougeard G;Sesboue R;Baert-Desurmont S;Vasseur S;Martin C;Tinat J;Brugieres L;Chompret A;de Paillerets BB;Stoppa-Lyonnet D;Bonaiti-Pellie C;Frebourg T;,2008,J Med Genet,45,535,538,18511570,,insC
187,Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families,Bougeard G;Sesboue R;Baert-Desurmont S;Vasseur S;Martin C;Tinat J;Brugieres L;Chompret A;de Paillerets BB;Stoppa-Lyonnet D;Bonaiti-Pellie C;Frebourg T;,2008,J Med Genet,45,535,538,18511570,,insCAG
187,Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families,Bougeard G;Sesboue R;Baert-Desurmont S;Vasseur S;Martin C;Tinat J;Brugieres L;Chompret A;de Paillerets BB;Stoppa-Lyonnet D;Bonaiti-Pellie C;Frebourg T;,2008,J Med Genet,45,535,538,18511570,,updated with RefID-449
188,Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome,Lin MT;Shieh JJ;Chang JH;Chang SW;Chen TC;Hsu WH;,2009,Pediatr Blood Cancer,52,541,544,19101993,,
189,Multiple tumors in a child with germ-line mutations in TP53 and PTEN,Plon SE;Pirics ML;Nuchtern J;Hicks J;Russell H;Agrawal S;Zbuk K;Eng C;Hegde M;Chin EL;,2008,N Engl J Med,359,537,539,18669439,,
190,"Early-onset of sporadic basal-cell carcinoma: germline mutations in the TP53, PTCH, and XPD genes",Suarez-Martinez EB;Ruiz A;Matias J;Morales L;Cruz A;Vazquez D;Villa J;Matta JL;,2007,P R Health Sci J,26,349,354,18246963,,
191,Germline p53 mutation in a Micronesian child with adrenocortical carcinoma and subsequent osteosarcoma,Delaney HM;Prauner RD;Person DA;,2008,J Pediatr Hematol Oncol,30,803,806,18989156,,
192,A molecular approach for identifying individuals with Li-Fraumeni syndrome who have a limited family history,Ang P;Lim IH;Yong RY;Lee AS;,2009,Clin Genet,75,294,297,19250386,,
193,Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene,Hwang SM;Lee ES;Shin SH;Kong SY;,2008,Korean J Lab Med,28,493,497,19127115,,
194,Identification of a novel TP53 germline mutation in a large Italian Li-Fraumeni syndrome Family,Capra V;Consales A;Nozza P;Monti P;Inga A;Fronza G;,2009,Pediatr Blood Cancer,52,303,304,18937320,,
195,Direct Submission,Janavicius R;,2009,Unpublished,,,,NA,www.santa.lt;One case published in Janavicius 2011,FC0056
195,Direct Submission,Janavicius R;,2009,Unpublished,,,,NA,www.santa.lt;One case published in Janavicius 2011,FC0057
195,Direct Submission,Janavicius R;,2009,Unpublished,,,,NA,www.santa.lt;One case published in Janavicius 2011,FC0055
196,TP53PIN3 and MDM2 SNP309 polymorphisms as genetic modifiers in the Li-Fraumeni syndrome: impact on age at first diagnosis,Marcel V;Palmero EI;Falagan-Lotsch P;Martel-Planche G;shton-Prolla P;Olivier M;Brentani RR;Hainaut P;Achatz MI;,2009,J Med Genet,46,766,772,19542078,,
197,IARC data,Verma I;Hainaut P;,2009,Unpublished,,,,NA,,
198,IARC data,Ariffin H;Hainaut P;,2009,Unpublished,,,,NA,,
199,IARC data,Vranic S;Hainaut P;,2009,Unpublished,,,,NA,,
200,A novel TP53 germline mutation in a family with a history of multiple malignancies: case report and review of the literature,Agarwalla PK;Dunn IF;Turner CD;Ligon KL;Schneider KA;Smith ER;,2008,Pediatr Neurosurg,44,501,508,19127094,,
201,Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population,Cao AY;Jin W;Shi PC;Di GH;Shen ZZ;Shao ZM;,2009,Breast Cancer Res Treat,119,295,303,19238535,,
202,"p53 tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li-Fraumeni syndrome and a child with adrenocortical carcinoma",Fiszer-Maliszewska L;Kazanowska B;Padzik J;,2009,Fam Cancer,8,541,546,19714490,,
204,The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30,Ginsburg OM;Akbari MR;Aziz Z;Young R;Lynch H;Ghadirian P;Robidoux A;Londono J;Vasquez G;Gomes M;Costa MM;Dimitrakakis C;Gutierrez G;Pilarski R;Royer R;Narod SA;,2009,Fam Cancer,,,,19714488,,BRCA1/2 negative
204,The prevalence of germ-line TP53 mutations in women diagnosed with breast cancer before age 30,Ginsburg OM;Akbari MR;Aziz Z;Young R;Lynch H;Ghadirian P;Robidoux A;Londono J;Vasquez G;Gomes M;Costa MM;Dimitrakakis C;Gutierrez G;Pilarski R;Royer R;Narod SA;,2009,Fam Cancer,,,,19714488,,
205,Virilizing adrenocortical carcinoma in a child with Turner syndrome and somatic TP53 gene mutation,Ko JH;Lee HS;Hong J;Hwang JS;,2009,Eur J Pediatr,,,,19701813,,
206,TP53 germline mutations in Portugal and genetic modifiers of age at cancer onset,Pinto C;Veiga I;Pinheiro M;Peixoto A;Pinto A;Lopes JM;Reis RM;Oliveira C;Baptista M;Roque L;Regateiro F;Cirnes L;Hofstra RM;Seruca R;Castedo S;Teixeira MR;,2009,Fam Cancer,,,,19468865,,
207,Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndrome,Rieber J;Remke M;Hartmann C;Korshunov A;Burkhardt B;Sturm D;Mechtersheimer G;Wittmann A;Greil J;Blattmann C;Witt O;Behnisch W;Halatsch ME;Orakcioglu B;von DA;Lichter P;Kulozik A;Pfister S;,2009,Genes Chromosomes Cancer,48,558,568,19378321,,
208,De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system,Schniederjan MJ;Shehata B;Brat DJ;Esiashvili N;Janss AJ;,2009,Pediatr Blood Cancer,,,,19711436,,
209,Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing,Schwarzbraun T;Obenauf AC;Langmann A;Gruber-Sedlmayr U;Wagner K;Speicher MR;Kroisel PM;,2009,J Med Genet,46,341,344,19269943,,hg18: chr17:7066210-7840187 del
210,Identification and characterization of a novel germline p53 mutation in a patient with glioblastoma and colon cancer,Yamada H;Shinmura K;Yamamura Y;Kurachi K;Nakamura T;Tsuneyoshi T;Yokota N;Maekawa M;Sugimura H;,2009,Int J Cancer,125,973,976,19405127,,
211,[Identification of a novel TP53 germline mutation in one child with adrenocortical carcinoma.],Si N;Sun M;Lu CX;Liu YS;Qi Z;Yang W;Zhao XL;Zhang X;,2009,Zhonghua Yi Xue Za Zhi,89,1402,1404,19671334,,insG
212,High frequency of de novo mutations in Li-Fraumeni syndrome,Gonzalez KD;Buzin CH;Noltner KA;Gu D;Li W;Malkin D;Sommer SS;,2009,J Med Genet,46,689,693,19556618,,
213,Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome,Taja-Chayeb L;Vidal-Millan S;Gutierrez-Hernandez O;Trejo-Becerril C;Perez-Cardenas E;Chavez-Blanco A;de lC;Duenas-Gonzalez A;,2009,World J Surg Oncol,7,97,,20017945,,
214,Germline TP53 mutations and single nucleotide polymorphisms in children,Valva P;Becker P;Streitemberger P;Lombardi GM;Rey G;Guzman CA;Preciado MV;,2009,Medicina (B Aires),69,143,147,19414295,,
215,Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN,Blanco A;Grana B;Fachal L;Santamarina M;Cameselle-Teijeiro J;Ruiz-Ponte C;Carracedo A;Vega A;,2010,Clin Genet,77,193,196,19930417,,BRCA1/2 WT
216,The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube,Xian W;Miron A;Roh M;Semmel DR;Yassin Y;Garber J;Oliva E;Goodman A;Mehra K;Berkowitz RS;Crum CP;Quade BJ;,2010,J Pathol,220,17,23,19834951,,
217,p53+/mdm2- atypical lipomatous tumor/well-differentiated liposarcoma in young children: an early expression of Li-Fraumeni syndrome,Debelenko LV;Perez-Atayde AR;Dubois SG;Grier HE;Pai SY;Shamberger RC;Kozakewich HP;,2010,Pediatr Dev Pathol,13,218,224,20028212,,
218,Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage,De Moura J;Kavalec FL;Doghman M;Rosati R;Custodio G;Lalli E;Cavallari GM;Santa MJ;Figueiredo BC;,2010,Int J Oncol,36,983,990,20198344,,
219,Li-Fraumeni syndrome in a Turkish family,Karakas Z;Tugcu D;Unuvar A;Atay D;Akcay A;Gedik H;Kayserili H;Dogan O;Anak S;Devecioglu O;,2010,Pediatr Hematol Oncol,27,297,305,20426520,,
220,Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation,Landolsi S;Gharbi O;Zrig M;Gribaa M;Njim L;Zakhama A;Abid A;Frebourg T;Ahmed SB;,2010,Ann Biol Clin (Paris),68,346,350,20478780,,
221,Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study,Mouchawar J;Korch C;Byers T;Pitts TM;Li E;McCredie MR;Giles GG;Hopper JL;Southey MC;,2010,Cancer Res,70,4795,4800,20501846,,
221,Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study,Mouchawar J;Korch C;Byers T;Pitts TM;Li E;McCredie MR;Giles GG;Hopper JL;Southey MC;,2010,Cancer Res,70,4795,4800,20501846,,may be duplicate of WAR92 (RefID111)
222,Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor,Pinto EM;Ribeiro RC;Kletter GB;Lawrence JP;Jenkins JJ;Wang J;Shurtleff S;McGregor L;Kriwacki RW;Zambetti GP;,2010,Fam Cancer,,,,20967502,,
223,TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes,Ruijs MW;Verhoef S;Rookus MA;Pruntel R;van der Hout AH;Hogervorst FB;Kluijt I;Sijmons RH;Aalfs CM;Wagner A;Ausems MG;Hoogerbrugge N;van Asperen CJ;Gomez Garcia EB;Meijers-Heijboer H;Ten Kate LP;Menko FH;van ';,2010,J Med Genet,47,421,428,20522432,,
224,A novel HER2-positive breast cancer phenotype arising from germline TP53 mutations,Wilson JR;Bateman AC;Hanson H;An Q;Evans G;Rahman N;Jones JL;Eccles DM;,2010,J Med Genet,47,771,774,20805372,corrections provided by D.Eccles,
225,IARC data,Ariffin H;,2011,Unpublished,,,,NA,Updated with ref-238,
226,IARC data,Achatz MI;,2011,Unpublished,,,,NA,,
227,Early occurrence of lung adenocarcinoma and breast cancer after radiotherapy of a chest wall sarcoma in a patient with a de novo germline mutation in TP53,Ferrarini A;uteri-Kaczmarek A;Pica A;Boesch N;Heinimann K;Schafer SC;Vesnaver-Megalo S;Cina V;Beckmann JS;Monnerat C;,2011,Fam Cancer,10,187,192,21225465,,
228,Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML,Link DC;Schuettpelz LG;Shen D;Wang J;Walter MJ;Kulkarni S;Payton JE;Ivanovich J;Goodfellow PJ;Le BM;Koboldt DC;Dooling DJ;Fulton RS;Bender RH;Fulton LL;Delehaunty KD;Fronick CC;Appelbaum EL;Schmidt H;Abbott R;O'Laughlin M;Chen K;McLellan MD;Varghese N;Nag,2011,JAMA,305,1568,1576,21505135,,
229,Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome,Heymann S;Delaloge S;Rahal A;Caron O;Frebourg T;Barreau L;Pachet C;Mathieu MC;Marsiglia H;Bourgier C;,2010,Radiat Oncol,5,104,,21059199,,
230,Novel germ line mutation p53-P177R in adult adrenocortical carcinoma producing neuron-specific enolase as a possible marker,Ide H;Terado Y;Tokiwa S;Nishio K;Saito K;Isotani S;Kamiyama Y;Muto S;Imamura T;Horie S;,2010,Jpn J Clin Oncol,40,815,818,20421238,,
231,Acute lymphoblastic leukemia after temozolomide treatment for anaplastic astrocytoma in a child with a germline TP53 mutation,Momota H;Narita Y;Miyakita Y;Hosono A;Makimoto A;Shibui S;,2010,Pediatr Blood Cancer,55,577,579,20658636,,
232,Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation,Robertson LB;Armstrong GN;Olver BD;Lloyd AL;Shete S;Lau C;Claus EB;Barnholtz-Sloan J;Lai R;Il'yasova D;Schildkraut J;Bernstein JL;Olson SH;Jenkins RB;Yang P;Rynearson AL;Wrensch M;McCoy L;Wienkce JK;McCarthy B;Davis F;Vick NA;Johansen C;Bodtcher H;Sadetzk,2010,Fam Cancer,9,413,421,20455025,,
233,Rhabdomyosarcoma-associated renal cell carcinoma: a link with constitutional Tp53 mutation,Curry S;Ibrahim F;Grehan D;McDermott M;Capra M;Betts D;O'Sullivan M;,2011,Pediatr Dev Pathol,14,248,251,21054160,,
234,Late onset Li-Fraumeni syndrome with bilateral breast cancer and other malignancies: case report and review of the literature,Kast K;Krause M;Schuler M;Friedrich K;Thamm B;Bier A;Distler W;Kruger S;,2012,BMC Cancer,12,217,,22672556,,
235,Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome,Sugawara W;Arai Y;Kasai F;Fujiwara Y;Haruta M;Hosaka R;Nishida K;Kurosumi M;Kobayashi Y;Akagi K;Kaneko Y;,2011,Genes Chromosomes Cancer,50,535,545,21484931,,
236,The R337H mutation in TP53 and breast cancer in Brazil,Gomes MC;Kotsopoulos J;de Almeida GL;Costa MM;Vieira R;Filho FA;Pitombo MB;PR FL;Royer R;Zhang P;Narod SA;,2012,Hered Cancer Clin Pract,10,3,,22455664,,
237,"Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms",Schulz E;Valentin A;Ulz P;Beham-Schmid C;Lind K;Rupp V;Lackner H;Wolfler A;Zebisch A;Olipitz W;Geigl J;Berghold A;Speicher MR;Sill H;,2012,J Med Genet,49,422,428,22652532,,
238,Childhood adrenocortical carcinoma as a sentinel cancer for detecting families with germline TP53 mutations,Choong S;Latiff Z;Mohamed M;Lim L;Chen K;Vengidasan L;Razali H;Abdul RE;Ariffin H;,2012,Clin Genet,,,,22233476,,
239,Functional studies of a novel germline p53 splicing mutation identified in a patient with Li-Fraumeni-like syndrome,Piao J;Sakurai N;Iwamoto S;Nishioka J;Nakatani K;Komada Y;Mizutani S;Takagi M;,2012,Mol Carcinog,,,,22495821,,
240,"Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: A population-based survey",Magnusson S;Gisselsson D;Wiebe T;Kristoffersson U;Borg A;Olsson H;,2012,Pediatr Blood Cancer,,,,22653678,,
241,"BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma",Pennington KP;Walsh T;Lee M;Pennil C;Novetsky AP;Agnew KJ;Thornton A;Garcia R;Mutch D;King MC;Goodfellow P;Swisher EM;,2012,Cancer,,,,22811390,,
242,"Comparable frequency of BRCA1, BRCA2 and TP53 germline mutations in a multi-ethnic Asian cohort suggests TP53 screening should be offered together with BRCA1/2 screening to early-onset breast cancer patients",Lee DS;Yoon SY;Looi LM;Kang P;Kang IN;Sivanandan K;Ariffin H;Thong MK;Chin KF;Mohd Taib NA;Yip CH;Teo SH;,2012,Breast Cancer Res,14,,,22507745,,
243,A prospective biological study in relation to a family with Li-Fraumeni syndrome,Aurtenetxe SO;Calvo B;Fernandez-Teijeiro A;Perez P;Navajas A;,2012,Clin Transl Oncol,14,396,398,22551548,,
244,Therapy-related myeloid neoplasm in a patient with TP53 mutation: a dilemma in allogeneic stem cell transplant,Kim MK;Cho HS;Bae YK;Lee KH;Ki CS;Lee ST;Hyun MS;,2010,Leuk Lymphoma,51,1144,1147,20443677,,
254,Direct submission,Mai P;,2013,Unpublished,,,,NA,,
255,High Frequency of Germline TP53 Mutations in a Prospective Adult-Onset Sarcoma Cohort,Mitchell G;Ballinger ML;Wong S;Hewitt C;James P;Young MA;Cipponi A;Pang T;Goode DL;Dobrovic A;Thomas DM;,2013,PLoS One,8,,,23894400,additional data from direct submission,
256,"Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil",Carraro DM;Koike Folgueira MA;Garcia Lisboa BC;Ribeiro Olivieri EH;Vitorino Krepischi AC;de Carvalho AF;de Carvalho Mota LD;Puga RD;do Socorro MM;Michelli RA;de Lyra EC;Grosso SH;Soares FA;de Souza Waddington Achatz MI;Brentani H;Moreira-Filho CA;Brentani MM;,2013,PLoS One,8,,,23469205,,
257,Whole exome sequencing of pediatric gastric adenocarcinoma reveals an atypical presentation of Li-Fraumeni syndrome,Chang VY;Federman N;Martinez-Agosto J;Tatishchev SF;Nelson SF;,2013,Pediatr Blood Cancer,60,570,574,23015295,,
258,A young woman with bilateral breast cancer: identifying a genetic cause and implications for management,de Bruin MA;Ford JM;Kurian AW;,2013,J Natl Compr Canc Netw,11,512,517,23667202,,
259,TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient,Giacomazzi J;Selistre S;Duarte J;Ribeiro JP;Vieira PJ;de Souza MG;Rossi C;Czepielewski M;Netto CB;Hainaut P;shton-Prolla P;,2013,BMC Cancer,13,187,,23570263,,
261,TP53 germline mutations in adult patients with adrenocortical carcinoma,Herrmann LJ;Heinze B;Fassnacht M;Willenberg HS;Quinkler M;Reisch N;Zink M;Allolio B;Hahner S;,2012,J Clin Endocrinol Metab,97,,,22170717,,
261,TP53 germline mutations in adult patients with adrenocortical carcinoma,Herrmann LJ;Heinze B;Fassnacht M;Willenberg HS;Quinkler M;Reisch N;Zink M;Allolio B;Hahner S;,2012,J Clin Endocrinol Metab,97,,,22170717,,R337H allele distinct from the Brazilian one
262,De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristics,Ismael O;Shimada A;Hama A;Elshazley M;Muramatsu H;Goto A;Sakaguchi H;Tanaka M;Takahashi Y;Yinyan X;Fukuda M;Miyajima Y;Yamashita Y;Horibe K;Hanada R;Ito M;Kojima S;,2012,Br J Haematol,158,129,137,22571758,,
263,Pleomorphic carcinoma of the lung arising in a patient with Li-Fraumeni syndrome: report of a case,Kato T;Ishikawa K;Satoh M;Kondo S;Kaji M;,2011,Surg Today,41,841,845,21626334,,
265,Routine TP53 testing for breast cancer under age 30: ready for prime time?,McCuaig JM;Armel SR;Novokmet A;Ginsburg OM;Demsky R;Narod SA;Malkin D;,2012,Fam Cancer,11,607,613,22851211,,
266,Early onset HER2-positive breast cancer is associated with germline TP53 mutations,Melhem-Bertrandt A;Bojadzieva J;Ready KJ;Obeid E;Liu DD;Gutierrez-Barrera AM;Litton JK;Olopade OI;Hortobagyi GN;Strong LC;Arun BK;,2012,Cancer,118,908,913,21761402,,
267,[Radiation-induced Intracranial Osteosarcoma after Radiation for Acute Lymphocytic Leukemia Associated with Li-Fraumeni Syndrome],Yoshimura J;Natsumeda M;Nishihira Y;Nishiyama K;Saito A;Okamoto K;Takahashi H;Fujii Y;,2013,No Shinkei Geka,41,499,505,23732761,,
268,The germline TP53 mutation c.722 C>T promotes bone and liver tumorigenesis at a young age,Osumi T;Miharu M;Fuchimoto Y;Morioka H;Kosaki K;Shimada H;,2012,Pediatr Blood Cancer,59,1332,1333,22887876,,
269,"An identical, complex TP53 mutation arising independently in two unrelated families with diverse cancer profiles: the complexity of interpreting cancer risk in carriers",Pinto EM;Ribeiro RC;Li J;Taja-Chayeb L;Carrasco LF;de LP;Vidal-Millan S;Maldonado-Mtz H;Duenas-Gonzalez A;McGregor L;Zambetti GP;,2012,Oncogenesis,1,,,23552518,,
270,Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing,Powell BC;Jiang L;Muzny DM;Trevino LR;Dreyer ZE;Strong LC;Wheeler DA;Gibbs RA;Plon SE;,2013,Pediatr Blood Cancer,60,,,23255406,,updated with Ref_ID 427
271,Prevalence of germline TP53 mutations in HER2+ breast cancer patients,Rath MG;Masciari S;Gelman R;Miron A;Miron P;Foley K;Richardson AL;Krop IE;Verselis SJ;Dillon DA;Garber JE;,2013,Breast Cancer Res Treat,139,193,198,23580068,,
272,Novel p53 splicing site mutation in Li-Fraumeni-like syndrome with osteosarcoma,Sakurai N;Iwamoto S;Miura Y;Nakamura T;Matsumine A;Nishioka J;Nakatani K;Komada Y;,2013,Pediatr Int,55,107,111,23409989,,
273,Novel human pathological mutations. Gene symbol: TP53. Disease: Li-Fraumeni syndrome,Saxena R;Kohli S;Guleria K;Verma IC;,2010,Hum Genet,127,480,,21488255,,
274,Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study,Villani A;Tabori U;Schiffman J;Shlien A;Beyene J;Druker H;Novokmet A;Finlay J;Malkin D;,2011,Lancet Oncol,12,559,567,21601526,,
275,Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations,Rausch T;Jones DT;Zapatka M;Stutz AM;Zichner T;Weischenfeldt J;Jager N;Remke M;Shih D;Northcott PA;Pfaff E;Tica J;Wang Q;Massimi L;Witt H;Bender S;Pleier S;Cin H;Hawkins C;Beck C;von DA;Hans V;Brors B;Eils R;Scheurlen W;Blake J;Benes V;Kulozik AE;Witt O;Martin D;Zhang C;Porat R;Merino DM;Wasserman J;Jabado N;Fontebasso A;Bullinger L;Rucker FG;Dohner K;Dohner H;Koster J;Molenaar JJ;Versteeg R;Kool M;Tabori U;Malkin D;Korshunov A;Taylor MD;Lichter P;Pfister SM;Korbel JO;,2012,Cell,148,59,71,22265402,,
276,Clinical impact of TP53 alterations in adrenocortical carcinomas,Waldmann J;Patsalis N;Fendrich V;Langer P;Saeger W;Chaloupka B;Ramaswamy A;Fassnacht M;Bartsch DK;Slater EP;,2012,Langenbecks Arch Surg,397,209,216,22203015,,
277,Increased oxidative metabolism in the Li-Fraumeni syndrome,Wang PY;Ma W;Park JY;Celi FS;Arena R;Choi JW;Ali QA;Tripodi DJ;Zhuang J;Lago CU;Strong LC;Talagala SL;Balaban RS;Kang JG;Hwang PM;,2013,N Engl J Med,368,1027,1032,23484829,,
278,Multiple malignancies in a child with de novo TP53 mutation,Wozniak A;Fryer A;Grimer R;Mc DH;,2011,Pediatr Hematol Oncol,28,338,343,21345075,,
279,"Joint effects of germ-line TP53 mutation, MDM2 SNP309, and gender on cancer risk in family studies of Li-Fraumeni syndrome",Wu CC;Krahe R;Lozano G;Zhang B;Wilson CD;Jo EJ;Amos CI;Shete S;Strong LC;,2011,Hum Genet,129,663,673,21305319,,
280,Drastic effect of germline TP53 missense mutations in Li-Fraumeni patients,Zerdoumi Y;ury-Landas J;Bonaiti-Pellie C;Derambure C;Sesboue R;Renaux-Petel M;Frebourg T;Bougeard G;Flaman JM;,2013,Hum Mutat,34,453,461,23172776,,
281,Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil,Custodio G;Taques GR;Figueiredo BC;Gugelmin ES;Oliveira Figueiredo MM;Watanabe F;Pontarolo R;Lalli E;Torres LF;,2011,PLoS One,6,,,21445348,,
282,Clinical and molecular aspects of a pediatric metachronous adrenocortical tumor,Lima LO;Lerario AM;Alencar GA;Brito LP;Almeida MQ;Domenice S;Latronico AC;Mendonca BB;Fragoso MC;,2011,Arq Bras Endocrinol Metabol,55,72,77,21468523,,
284,A pathogenic mosaic TP53 mutation in two germ layers detected by next generation sequencing,Behjati S;Maschietto M;Williams RD;Side L;Hubank M;West R;Pearson K;Sebire N;Tarpey P;Futreal A;Brooks T;Stratton MR;Anderson J;,2014,PLoS One,9,,,24810334,,
285,Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer,Bell K;Hodgson N;Levine M;Sadikovic B;Zbuk K;,2014,Breast Cancer Res Treat,146,447,450,24916180,,
286,Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes,Castera L;Krieger S;Rousselin A;Legros A;Baumann JJ;Bruet O;Brault B;Fouillet R;Goardon N;Letac O;Baert-Desurmont S;Tinat J;Bera O;Dugast C;Berthet P;Polycarpe F;Layet V;Hardouin A;Frebourg T;Vaur D;,2014,Eur J Hum Genet,,,,24549055,,
287,Germline TP53 mutations is common in patients with two early-onset primary malignancies,Chak BP;Chan ES;Tong JH;Leung AW;Cheng FW;Lam GK;Shing MM;Li CK;To KF;,2015,Clin Genet,87,499,501,25293557,,
288,A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancer,Cho Y;Kim J;Kim Y;Jeong J;Lee KA;,2013,Ann Lab Med,33,212,216,23667851,,
289,Inherited predisposition to breast cancer among African American women,Churpek JE;Walsh T;Zheng Y;Moton Z;Thornton AM;Lee MK;Casadei S;Watts A;Neistadt B;Churpek MM;Huo D;Zvosec C;Liu F;Niu Q;Marquez R;Zhang J;Fackenthal J;King MC;Olopade OI;,2015,Breast Cancer Res Treat,149,31,39,25428789,,
290,Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation,Courtney R;Ranganathan S;,2014,J Pediatr Hematol Oncol,,,,25374282,,
291,TP53 p.R337H prevalence in a series of Brazilian hereditary breast cancer families,Cury NM;Ferraz VE;Silva WA;,2014,Hered Cancer Clin Pract,12,8,,24625245,,
293,EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature,Ricordel C;Labalette-Tiercin M;Lespagnol A;Kerjouan M;Dugast C;Mosser J;Desrues B;Lena H;,2015,Lung Cancer,87,80,84,25433984,,"childhood tumors in descendants, NOS"
293,EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: report of two cases and review of the literature,Ricordel C;Labalette-Tiercin M;Lespagnol A;Kerjouan M;Dugast C;Mosser J;Desrues B;Lena H;,2015,Lung Cancer,87,80,84,25433984,,
294,Successful treatment of a patient with Li-Fraumeni syndrome and metastatic lung adenocarcinoma harboring synchronous EGFR L858R and ERBB2 extracellular domain S310F mutations with the pan-HER inhibitor afatinib,Jia Y;Ali SM;Saad S;Chan CA;Miller VA;Halmos B;,2014,Cancer Biol Ther,15,970,974,24835218,,
295,Clinical response to a lapatinib-based therapy for a Li-Fraumeni syndrome patient with a novel HER2V659E mutation,Serra V;Vivancos A;Puente XS;Felip E;Silberschmidt D;Caratu G;Parra JL;De Mattos-Arruda L;Grueso J;Hernandez-Losa J;Arribas J;Prudkin L;Nuciforo P;Scaltriti M;Seoane J;Baselga J;,2013,Cancer Discov,3,1238,1244,23950206,,
296,EGFR-mutated lung cancer in Li-Fraumeni syndrome,Michalarea V;Calcasola M;Cane P;Tobal K;Izatt L;Spicer J;,2014,Lung Cancer,,,,25047674,,Updated info (BRCA2 status) from Dr Izatt
297,Genetic evaluation based on family history and Her2 status correctly identifies TP53 mutations in very early onset breast cancer cases,Fostira F;Konstantopoulou I;Mavroudis D;Tryfonopoulos D;Yannoukakos D;Voutsinas GE;,2014,Clin Genet,,,,24702488,,
298,Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma,Heitzer E;Lax S;Lafer I;Muller SM;Pristauz G;Ulz P;Jahn S;Hogenauer C;Petru E;Speicher MR;Geigl JB;,2013,BMC Med Genet,14,129,,24373500,,Add info from REF_ID 381
299,Establishment and characterization of the first pediatric adrenocortical carcinoma xenograft model identifies topotecan as a potential chemotherapeutic agent,Pinto EM;Morton C;Rodriguez-Galindo C;McGregor L;Davidoff AM;Mercer K;Debelenko LV;Billups C;Ribeiro RC;Zambetti GP;,2013,Clin Cancer Res,19,1740,1747,23406775,,
300,Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li-Fraumeni syndrome,Etzold A;Schroder JC;Bartsch O;Zechner U;Galetzka D;,2014,Fam Cancer,,,,25226867,,
303,Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer,Grant RC;Selander I;Connor AA;Selvarajah S;Borgida A;Briollais L;Petersen GM;Lerner-Ellis J;Holter S;Gallinger S;,2014,Gastroenterology,,,,25479140,,
304,Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers,Hettmer S;Archer NM;Somers GR;Novokmet A;Wagers AJ;Diller L;Rodriguez-Galindo C;Teot LA;Malkin D;,2014,Cancer,120,1068,1075,24382691,,
305,Integrated analysis of germline and somatic variants in ovarian cancer,Kanchi KL;Johnson KJ;Lu C;McLellan MD;Leiserson MD;Wendl MC;Zhang Q;Koboldt DC;Xie M;Kandoth C;McMichael JF;Wyczalkowski MA;Larson DE;Schmidt HK;Miller CA;Fulton RS;Spellman PT;Mardis ER;Druley TE;Graubert TA;Goodfellow PJ;Raphael BJ;Wilson RK;Ding L;,2014,Nat Commun,5,3156,,24448499,,
306,Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition,Kool M;Jones DT;Jager N;Northcott PA;Pugh TJ;Hovestadt V;Piro RM;Esparza LA;Markant SL;Remke M;Milde T;Bourdeaut F;Ryzhova M;Sturm D;Pfaff E;Stark S;Hutter S;Seker-Cin H;Johann P;Bender S;Schmidt C;Rausch T;Shih D;Reimand J;Sieber L;Wittmann A;Linke L;Wit,2014,Cancer Cell,25,393,405,24651015,,
307,Li-Fraumeni syndrome: multiple distinct brain tumours in two brothers,Lechien JR;Brotchi J;Van ML;Costa de AP;Bruninx G;Hilbert P;Nubourgh Y;,2014,Neurochirurgie,60,51,54,24636404,,
308,Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel,Tung N;Battelli C;Allen B;Kaldate R;Bhatnagar S;Bowles K;Timms K;Garber JE;Herold C;Ellisen L;Krejdovsky J;DeLeonardis K;Sedgwick K;Soltis K;Roa B;Wenstrup RJ;Hartman AR;,2015,Cancer,121,25,33,25186627,,
309,Germline TP53 variants and susceptibility to osteosarcoma,Mirabello L;Yeager M;Mai PL;Gastier-Foster JM;Gorlick R;Khanna C;Patino-Garcia A;Sierrasesumaga L;Lecanda F;Andrulis IL;Wunder JS;Gokgoz N;Barkauskas DA;Zhang X;Vogt A;Jones K;Boland JF;Chanock SJ;Savage SA;,2015,J Natl Cancer Inst,107,,,25896519,,
310,Two co-existing germline mutations P53 V157D and PMS2 R20Q promote tumorigenesis in a familial cancer syndrome,Wang Z;Sun Y;Gao B;Lu Y;Fang R;Gao Y;Xiao T;Liu XY;Pao W;Zhao Y;Chen H;Ji H;,2014,Cancer Lett,342,36,42,23981578,,
311,Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study,Wasserman JD;Novokmet A;Eichler-Jonsson C;Ribeiro RC;Rodriguez-Galindo C;Zambetti GP;Malkin D;,2015,J Clin Oncol,,,,25584008,,
311,Prevalence and Functional Consequence of TP53 Mutations in Pediatric Adrenocortical Carcinoma: A Children's Oncology Group Study,Wasserman JD;Novokmet A;Eichler-Jonsson C;Ribeiro RC;Rodriguez-Galindo C;Zambetti GP;Malkin D;,2015,J Clin Oncol,,,,25584008,,TP53 mutation: Q52fs (NOS)
312,Lack of toxicity in a patient with germline TP53 mutation treated with radiotherapy,Wong P;Han K;,2014,Curr Oncol,21,,,24764719,,
313,TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome,Ribi S;Baumhoer D;Lee K;Edison;Teo AS;Madan B;Zhang K;Kohlmann WK;Yao F;Lee WH;Hoi Q;Cai S;Woo XY;Tan P;Jundt G;Smida J;Nathrath M;Sung WK;Schiffman JD;Virshup DM;Hillmer AM;,2015,Oncotarget,6,7727,7740,25762628,,no detailed info on tumors and patients
315,Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing,Yang X;Wu J;Lu J;Liu G;Di G;Chen C;Hou Y;Sun M;Yang W;Xu X;Zhao Y;Hu X;Li D;Cao Z;Zhou X;Huang X;Liu Z;Chen H;Gu Y;Chi Y;Yan X;Han Q;Shen Z;Shao Z;Hu Z;,2015,PLoS One,10,,,25927356,,
316,Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry,Yurgelun MB;Masciari S;Joshi VA;Mercado RC;Lindor NM;Gallinger S;Hopper JL;Jenkins MA;Buchanan DD;Newcomb PA;Potter JD;Haile RW;Kucherlapati R;Syngal S;,2015,JAMA Oncol,1,214,221,26086041,,
317,TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family,Kappel S;Janschek E;Wolf B;Rudas M;Teleky B;Jakesz R;Kandioler D;,2015,Breast Cancer Res Treat,151,671,678,25981898,,
318,A child with Li-Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignancies,Schlegelberger B;Kreipe H;Lehmann U;Steinemann D;Ripperger T;Gohring G;Thomay K;Rump A;Di DN;Suttorp M;,2015,Pediatr Blood Cancer,62,1481,1484,25787918,,
319,Germline TP53 mutational spectrum in French Canadians with breast cancer,Arcand SL;Akbari MR;Mes-Masson AM;Provencher D;Foulkes WD;Narod SA;Tonin PN;,2015,BMC Med Genet,16,24,,25925845,,
320,Transmission of germline TP53 mutations from male carriers to female partners,Patrier-Sallebert S;Bougeard G;Baert-Desurmont S;Lamy A;Flaman JM;Mansuy L;Bronner M;Lasset C;Brugieres L;Golfier F;Frebourg T;,2015,J Med Genet,52,145,146,25612911,,
321,Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage,Zerdoumi Y;Lanos R;Raad S;Flaman JM;Bougeard G;Frebourg T;Tournier I;,2017,Hum Mol Genet,26,2812,,28472496,,incomplete pedigree
321,Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage,Zerdoumi Y;Lanos R;Raad S;Flaman JM;Bougeard G;Frebourg T;Tournier I;,2017,Hum Mol Genet,26,2812,,28472496,,incomplete pedigree; updated with RefID-449
322,Does PTEN gene mutation play any role in Li-Fraumeni syndrome,Akouchekian M;Hemati S;Jafari D;Jalilian N;Dehghan MM;,2016,Med J Islam Repub Iran,30,378,,27493922,,
323,TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes,Andrade RC;Dos Santos AC;de Aguirre Neto JC;Nevado J;Lapunzina P;Vargas FR;,2017,Fam Cancer,16,243,248,27714481,,
324,TP53 germline and somatic mutations in a patient with fibrolamellar hepatocellular carcinoma,Andrade RC;de Lima MAFD;de Faria PAS;Vargas FR;,2017,Fam Cancer,,,,28477317,,
326,Gestational choriocarcinoma associated with a germline TP53 mutation,Brehin AC;Patrier-Sallebert S;Bougeard G;Side-Pfennig G;Llamas GF;Lamy A;Colasse E;Kandel-Aznar C;Delnatte C;Vuillemin E;Sadot-Lebouvier S;Odent S;Sabourin JC;Golfier F;Frebourg T;,2018,Fam Cancer,,,,28477316,,
327,Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome,Buzby JS;Williams SA;Schaffer L;Head SR;Nugent DJ;,2017,Cancer Genet,211,9,17,28279309,,
328,Germline Mutations in Cancer Predisposition Genes are Frequent in Sporadic Sarcomas,Chan SH;Lim WK;Ishak NDB;Li ST;Goh WL;Tan GS;Lim KH;Teo M;Young CNC;Malik S;Tan MH;Teh JYH;Chin FKC;Kesavan S;Selvarajan S;Tan P;Teh BT;Soo KC;Farid M;Quek R;Ngeow J;,2017,Sci Rep,7,10660,,28878254,,
329,Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia,Churpek JE;Marquez R;Neistadt B;Claussen K;Lee MK;Churpek MM;Huo D;Weiner H;Bannerjee M;Godley LA;Le Beau MM;Pritchard CC;Walsh T;King MC;Olopade OI;Larson RA;,2016,Cancer,122,304,311,26641009,,"Famliy history: leukemia, brain, lung"
329,Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia,Churpek JE;Marquez R;Neistadt B;Claussen K;Lee MK;Churpek MM;Huo D;Weiner H;Bannerjee M;Godley LA;Le Beau MM;Pritchard CC;Walsh T;King MC;Olopade OI;Larson RA;,2016,Cancer,122,304,311,26641009,,Family history: sarcoma
329,Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia,Churpek JE;Marquez R;Neistadt B;Claussen K;Lee MK;Churpek MM;Huo D;Weiner H;Bannerjee M;Godley LA;Le Beau MM;Pritchard CC;Walsh T;King MC;Olopade OI;Larson RA;,2016,Cancer,122,304,311,26641009,,
330,Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma,Cornelius A;Foley J;Bond J;Nagulapally AB;Steinbrecher J;Hendricks WPD;Rich M;Yendrembam S;Bergendahl G;Trent JM;Sholler GS;,2017,Front Pharmacol,8,652,,28993730,,
331,Transmission of a TP53 germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner1,Cotter JA;Szymanski L;Karimov C;Boghossian L;Margol A;Dhall G;Tamrazi B;Varaprasathan GI;Parham DM;Judkins AR;Biegel JA;,2018,Cold Spring Harb Mol Case Stud,4,,,29581140,,
334,Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC),DiNardo CD;Bannon SA;Routbort M;Franklin A;Mork M;Armanios M;Mace EM;Orange JS;Jeff-Eke M;Churpek JE;Takahashi K;Jorgensen JL;Garcia-Manero G;Kornblau S;Bertuch A;Cheung H;Bhalla K;Futreal A;Godley LA;Patel KP;,2016,Clin Lymphoma Myeloma Leuk,16,417,428,27210295,,
335,Undefined familial colorectal cancer and the role of pleiotropism in cancer susceptibility genes,Dobbins SE;Broderick P;Chubb D;Kinnersley B;Sherborne AL;Houlston RS;,2016,Fam Cancer,15,593,599,27356891,,
336,Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile,Franceschi S;Spugnesi L;Aretini P;Lessi F;Scarpitta R;Galli A;Congregati C;Caligo MA;Mazzanti CM;,2017,Carcinogenesis,38,938,943,28911001,,
337,Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP531,Lolas HS;Renbaum P;Kamal L;Dweik D;Salahat M;Jaraysa T;Abu RA;Casadei S;Mandell JB;Gulsuner S;Lee MK;Walsh T;King MC;Levy-Lahad E;Kanaan M;,2017,Int J Cancer,141,750,756,28486781,,
340,Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer1,Hauke J;Horvath J;Gross E;Gehrig A;Honisch E;Hackmann K;Schmidt G;Arnold N;Faust U;Sutter C;Hentschel J;Wang-Gohrke S;Smogavec M;Weber BHF;Weber-Lassalle N;Weber-Lassalle K;Borde J;Ernst C;Altmuller J;Volk AE;Thiele H;Hubbel V;Nurnberg P;Keupp K;Versmold,2018,Cancer Med,7,1349,1358,29522266,,
341,Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas,Hayes J;Yu Y;Jalbert LE;Mazor T;Jones LE;Wood MD;Walsh KM;Bengtsson H;Hong C;Oberndorfer S;Roetzer T;Smirnov IV;Clarke JL;Aghi MK;Chang SM;Nelson SJ;Woehrer A;Phillips JJ;Solomon DA;Costello JF;,2017,Neuro Oncol,,,,29077933,,
342,Pathogenic Mutations in Cancer-Predisposing Genes: A Survey of 300 Patients with Whole-Genome Sequencing and Lifetime Electronic Health Records,He KY;Zhao Y;McPherson EW;Li Q;Xia F;Weng C;Wang K;He MM;,2016,PLoS One,11,,,27930734,,
343,"Pathogenic Germline Variants in 10,389 Adult Cancers1",Huang KL;Mashl RJ;Wu Y;Ritter DI;Wang J;Oh C;Paczkowska M;Reynolds S;Wyczalkowski MA;Oak N;Scott AD;Krassowski M;Cherniack AD;Houlahan KE;Jayasinghe R;Wang LB;Zhou DC;Liu D;Cao S;Kim YW;Koire A;McMichael JF;Hucthagowder V;Kim TB;Hahn A;Wang C;McLellan MD;,2018,Cell,173,355,370,29625052,,TCGA case
344,Genetic and functional analysis of a Li Fraumeni syndrome family in China,Hu H;Liu J;Liao X;Zhang S;Li H;Lu R;Li X;Lin W;Liu M;Xia Z;Qing G;Li JD;,2016,Sci Rep,6,20221,,26818906,,
345,Next-generation sequencing in familial breast cancer patients from Lebanon,Jalkh N;Chouery E;Haidar Z;Khater C;Atallah D;Ali H;Marafie MJ;Al-Mulla MR;Al-Mulla F;Megarbane A;,2017,BMC Med Genomics,10,8,,28202063,,
346,The benefit and burden of cancer screening in Li-Fraumeni syndrome: a case report,Jhaveri AP;Bale A;Lovick N;Zuckerman K;Deshpande H;Rath K;Schwartz P;Hofstatter EW;,2015,Yale J Biol Med,88,181,185,26029016,,
347,A novel dysfunctional germline P53 mutation identified in a family with Li-Fraumeni syndrome1,Ji M;Wang L;Shao Y;Cao W;Xu T;Chen S;Wang Z;He Q;Yang K;,2018,Am J Cancer Res,8,165,169,29416929,,
348,Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients,Keel SB;Scott A;Sanchez-Bonilla M;Ho PA;Gulsuner S;Pritchard CC;Abkowitz JL;King MC;Walsh T;Shimamura A;,2016,Haematologica,101,1343,1350,27418648,,
349,A novel germline TP53 mutation p.Pro190Arg detected in a patient with lung and bilateral breast cancers,Krzesniak M;Butkiewicz D;Rachtan J;Matuszczyk I;Grzybowska E;Rusin M;,2017,Adv Med Sci,62,207,210,28499267,,
350,Autism spectrum disorder and Li-Fraumeni syndrome: purely coincidental or mechanistically associated?,Kuhlen M;Taeubner J;Wieczorek D;Borkhardt A;,2017,Mol Cell Pediatr,4,8,,28983852,,
351,Detection of Germline Mutation in Hereditary Breast and/or Ovarian Cancers by Next-Generation Sequencing on a Four-Gene Panel,Kwong A;Shin VY;Au CH;Law FB;Ho DN;Ip BK;Wong AT;Lau SS;To RM;Choy G;Ford JM;Ma ES;Chan TL;,2016,J Mol Diagn,18,580,594,27157322,,
352,Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families,Li J;Meeks H;Feng BJ;Healey S;Thorne H;Makunin I;Ellis J;Campbell I;Southey M;Mitchell G;Clouston D;Kirk J;Goldgar D;Chenevix-Trench G;,2016,J Med Genet,53,34,42,26534844,,
353,Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer,Lin PH;Kuo WH;Huang AC;Lu YS;Lin CH;Kuo SH;Wang MY;Liu CY;Cheng FT;Yeh MH;Li HY;Yang YH;Hsu YH;Fan SC;Li LY;Yu SL;Chang KJ;Chen PL;Ni YH;Huang CS;,2016,Oncotarget,7,8310,8320,26824983,,
354,Genetic analysis in a patient with nine primary malignant neoplasms: a rare case of Li-Fraumeni syndrome,Li X;Kang J;Pan Q;Sikora-Wohlfeld W;Zhao D;Meng C;Bai C;Patwardhan A;Chen R;Ren H;Butte AJ;Ding K;,2016,Oncol Rep,35,1519,1528,26707089,,
355,A novel TP53 germline inframe deletion identified in a Spanish series of Li-fraumeni syndrome suspected families,Llovet P;Illana FJ;Martin-Morales L;de la Hoya M;Garre P;Ibanez-Royo MD;Perez-Segura P;Caldes T;Garcia-Barberan V;,2017,Fam Cancer,16,567,575,28573494,,
356,Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol,Meric-Bernstam F;Brusco L;Daniels M;Wathoo C;Bailey AM;Strong L;Shaw K;Lu K;Qi Y;Zhao H;Lara-Guerra H;Litton J;Arun B;Eterovic AK;Aytac U;Routbort M;Subbiah V;Janku F;Davies MA;Kopetz S;Mendelsohn J;Mills GB;Chen K;,2016,Ann Oncol,27,795,800,26787237,,
357,Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literature,Nandikolla AG;Venugopal S;Anampa J;,2017,Breast Cancer (Dove Med Press),9,207,215,28356770,,
358,Next generation sequencing is informing phenotype: a TP53 example,O'Shea R;Clarke R;Berkley E;Giffney C;Farrell M;O'Donovan E;Gallagher DJ;,2017,Fam Cancer,,,,28509937,,
359,Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome,Park KJ;Choi HJ;Suh SP;Ki CS;Kim JW;,2016,Ann Lab Med,36,463,468,27374712,,
360,Osteosarcoma with Adenocarcinoma of Lung in Li-Fraumeni Syndrome: A Case Report,Oh CS;Lee JH;Jung ST;Na BR;,2014,J Korean Bone Joint Tumor Soc,20,99,103,NA,,
361,Family of Li-Fraumeni Syndrome with a Germline Mutation in the p53 Gene,Shin HJ;Kwon YJ;Lim YJ;Park BK;Ghim TT;Shin SH;Kong SY;Hong EK;Park HJ;,2009,Clin Pediatr Hematol Oncol,,38,42,NA,,
362,Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors,Parsons DW;Roy A;Yang Y;Wang T;Scollon S;Bergstrom K;Kerstein RA;Gutierrez S;Petersen AK;Bavle A;Lin FY;Lopez-Terrada DH;Monzon FA;Hicks MJ;Eldin KW;Quintanilla NM;Adesina AM;Mohila CA;Whitehead W;Jea A;Vasudevan SA;Nuchtern JG;Ramamurthy U;McGuire AL;Hil,2016,JAMA Oncol,,,,26822237,,
364,Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer,Rummel SK;Lovejoy L;Shriver CD;Ellsworth RE;,2017,Breast Cancer Res Treat,164,593,601,28503720,,
365,Baseline results from the UK SIGNIFY study: a whole-body MRI screening study in TP53 mutation carriers and matched controls,Saya S;Killick E;Thomas S;Taylor N;Bancroft EK;Rothwell J;Benafif S;Dias A;Mikropoulos C;Pope J;Chamberlain A;Gunapala R;Izatt L;Side L;Walker L;Tomkins S;Cook J;Barwell J;Wiles V;Limb L;Eccles D;Leach MO;Shanley S;Gilbert FJ;Hanson H;Gallagher D;Rajashan,2017,Fam Cancer,16,433,440,28091804,,
366,Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma,Schiavi A;Lavigne J;Turcotte R;Kasprzak L;Dumas N;Chong G;Freeman C;Alameldin M;Galiatsatos P;Palma L;Foulkes WD;,2015,Curr Oncol,22,317,325,26628864,,
367,Somatic and Germline TP53 Alterations in Second Malignant Neoplasms from Pediatric Cancer Survivors,Sherborne AL;Lavergne V;Yu K;Lee L;Davidson PR;Mazor T;Smirnoff IV;Horvai AE;Loh M;Dubois SG;Goldsby RE;Neglia JP;Hammond S;Robison LL;Wustrack R;Costello JF;Nakamura AO;Shannon KM;Bhatia S;Nakamura JL;,2017,Clin Cancer Res,23,1852,1861,27683180,,
368,Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma,Shindo K;Yu J;Suenaga M;Fesharakizadeh S;Cho C;Macgregor-Das A;Siddiqui A;Witmer PD;Tamura K;Song TJ;Navarro Almario JA;Brant A;Borges M;Ford M;Barkley T;He J;Weiss MJ;Wolfgang CL;Roberts NJ;Hruban RH;Klein AP;Goggins M;,2017,J Clin Oncol,35,3382,3390,28767289,,
369,Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome,Sinclair TJ;Thorson CM;Alvarez E;Tan S;Spunt SL;Chao SD;,2017,Pediatr Surg Int,33,631,635,28160093,,
370,Genetic Gastric Cancer Susceptibility in the International Clinical Cancer Genomics Community Research Network,Slavin T;Neuhausen SL;Rybak C;Solomon I;Nehoray B;Blazer K;Niell-Swiller M;Adamson AW;Yuan YC;Yang K;Sand S;Castillo D;Herzog J;Wu X;Tao S;Chavez T;Woo Y;Chao J;Mora P;Horcasitas D;Weitzel J;,2017,Cancer Genet,,111,119,29025585,,
371,The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels,Sung PL;Wen KC;Chen YJ;Chao TC;Tsai YF;Tseng LM;Qiu JT;Chao KC;Wu HH;Chuang CM;Wang PH;Huang CF;,2017,PLoS One,12,,,28961279,,
372,Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients,Sun J;Meng H;Yao L;Lv M;Bai J;Zhang J;Wang L;Ouyang T;Li J;Wang T;Fan Z;Fan T;Lin B;Xie Y;,2017,Clin Cancer Res,23,6113,6119,28724667,Individual level data (no pedigree info),
373,Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer,Couch FJ;Hart SN;Sharma P;Toland AE;Wang X;Miron P;Olson JE;Godwin AK;Pankratz VS;Olswold C;Slettedahl S;Hallberg E;Guidugli L;Davila JI;Beckmann MW;Janni W;Rack B;Ekici AB;Slamon DJ;Konstantopoulou I;Fostira F;Vratimos A;Fountzilas G;Pelttari LM;Tapper W,2015,J Clin Oncol,33,304,311,25452441,updated with PMID:30099541 (REF_ID 435),
374,Constitutional mosaicism of a de novo TP53 mutation in a patient with bilateral choroid plexus carcinoma,Trubicka J;Filipek I;Piotr I;Rydzanicz M;Grajkowska W;Piekutowska-Abramczuk D;Chrzanowska K;Karkucinska-Wieckowska A;Iwanicka-Pronicka K;Pronicki M;Lastowska M;Ploski R;Dembowska-Baginska B;,2017,Cancer Genet,,79,85,29025599,,
375,Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study,Villani A;Shore A;Wasserman JD;Stephens D;Kim RH;Druker H;Gallinger B;Naumer A;Kohlmann W;Novokmet A;Tabori U;Tijerin M;Greer ML;Finlay JL;Schiffman JD;Malkin D;,2016,Lancet Oncol,17,1295,1305,27501770,,
376,Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort,Waszak SM;Northcott PA;Buchhalter I;Robinson GW;Sutter C;Groebner S;Grund KB;Brugieres L;Jones DTW;Pajtler KW;Morrissy AS;Kool M;Sturm D;Chavez L;Ernst A;Brabetz S;Hain M;Zichner T;Segura-Wang M;Weischenfeldt J;Rausch T;Mardin BR;Zhou X;Baciu C;Lawerenz C,2018,Lancet Oncol,,,,29753700,,
377,Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore,Wong ESY;Shekar S;Met-Domestici M;Chan C;Sze M;Yap YS;Rozen SG;Tan MH;Ang P;Ngeow J;Lee ASG;,2016,NPJ Genom Med,1,15003,,29263802,,
378,[A rhabdomyosarcoma patient from a Li-Fraumeni syndrome family: a case report and literature review],Xie Y;Zhao WH;Hua Y;Sun Q;Wu PH;,2017,Zhongguo Dang Dai Er Ke Za Zhi,19,1263,1266,29237527,,
379,"Prevalence and spectrum of germline rare variants in BRCA1/2 and PALB2 among breast cancer cases in Sarawak, Malaysia",Yang XR;Devi BCR;Sung H;Guida J;Mucaki EJ;Xiao Y;Best A;Garland L;Xie Y;Hu N;Rodriguez-Herrera M;Wang C;Jones K;Luo W;Hicks B;Tang TS;Moitra K;Rogan PK;Dean M;,2017,Breast Cancer Res Treat,165,687,697,28664506,,
380,The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome,Yoshida T;Tajika M;Tanaka T;Ishihara M;Hirayama Y;Mizuno N;Hara K;Hijioka S;Imaoka H;Hieda N;Okuno N;Kinoshita T;Bhatia V;Shimizu Y;Yatabe Y;Yamao K;Niwa Y;,2017,Intern Med,56,295,300,28154273,,
381,Acute myeloid leukemia with TP53 germ line mutations,Zebisch A;Lal R;Muller M;Lind K;Kashofer K;Girschikofsky M;Fuchs D;Wolfler A;Geigl JB;Sill H;,2016,Blood,128,2270,2272,27621308,,
382,Recurrent TP53 missense mutation in cancer patients of Arab descent,Zick A;Kadouri L;Cohen S;Frohlinger M;Hamburger T;Zvi N;Plaser M;Avital E;Breuier S;Elian F;Salah A;Goldberg Y;Peretz T;,2017,Fam Cancer,16,295,301,27866339,,
383,Germline Mutations in Predisposition Genes in Pediatric Cancer,Zhang J;Walsh MF;Wu G;Edmonson MN;Gruber TA;Easton J;Hedges D;Ma X;Zhou X;Yergeau DA;Wilkinson MR;Vadodaria B;Chen X;McGee RB;Hines-Dowell S;Nuccio R;Quinn E;Shurtleff SA;Rusch M;Patel A;Becksfort JB;Wang S;Weaver MS;Ding L;Mardis ER;Wilson RK;Gajjar A;El,2015,N Engl J Med,373,2336,2346,26580448,Cases potentially reported previously were not included,
384,Surveillance Screening in Li-Fraumeni Syndrome: Raising Awareness of False Positives,Kumar P;Gill RM;Phelps A;Tulpule A;Matthay K;Nicolaides T;,2018,Cureus,10,,,29946497,,
385,From uncertainty to pathogenicity: Clinical and functional interrogation of a rare TP53 in-frame deletion,Quinn EA;Maciaszek JL;Pinto EM;Phillips AH;Berdy D;Khandwala M;Upadhyaya SA;Zambetti GP;Kriwacki RW;Ellison DW;Nichols KE;Kesserwan C;,2019,Cold Spring Harb Mol Case Stud,,,,30886117,,
386,Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors,Aceto GM;Awadelkarim KD;Di NM;Moscatello C;Pantalone MR;Verginelli F;Elwali NE;Mariani-Costantini R;,2019,Breast Cancer Res Treat,,,,30796655,,
387,Rare TP53 variant associated with Li-Fraumeni syndrome exhibits variable penetrance in a Saudi family,AlHarbi M;Mubarak N;AlMubarak L;Aljelaify R;AlSaeed M;Almutairi A;AlJabarat W;Alqubaishi F;Al-Subaie L;AlTassan N;Neben CL;Zhou AY;Abedalthagafi M;,2018,NPJ Genom Med,3,35,,30588330,,
388,TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort,Bakhuizen JJ;Hogervorst FB;Velthuizen ME;Ruijs MW;van EK;van Os TA;Gille JJ;Collee M;van den Ouweland AM;van Asperen CJ;Kets CM;Mensenkamp AR;Leter EM;Blok MJ;de Jong MM;Ausems MG;,2019,Fam Cancer,18,273,280,30607672,,
389,Frequent activating STAT3 mutations and novel recurrent genomic abnormalities detected in breast implant-associated anaplastic large cell lymphoma,Blombery P;Thompson E;Ryland GL;Joyce R;Byrne DJ;Khoo C;Lade S;Hertzberg M;Hapgood G;Marlton P;Deva A;Lindeman G;Fox S;Westerman D;Prince M;,2018,Oncotarget,9,,,30546832,,
390,Report of a bi-allelic truncating germline mutation in TP53,Brown NJ;Bhatia K;Teague J;White SM;Lo P;Challis J;Beshay V;Sullivan M;Malkin D;Hansford JR;,2019,Fam Cancer,18,101,104,29737433,,Parental consanguinity
391,Probable hereditary familial overlap syndrome with multiple synchronous lung tumors,Cardona AF;Zatarain-Barron ZL;Rubio C;Martinez S;Ruiz-Patino A;Ricaurte L;Serna A;Barrios R;Garzon JC;Navarrete C;Balaguera A;Corrales L;Rojas L;Arrieta O;,2018,Lung Cancer,124,279,282,30268473,,
392,Germline pathogenic variants identified in women with ovarian tumors,Carter NJ;Marshall ML;Susswein LR;Zorn KK;Hiraki S;Arvai KJ;Torene RI;McGill AK;Yackowski L;Murphy PD;Xu Z;Solomon BD;Klein RT;Hruska KS;,2018,Gynecol Oncol,151,481,488,30322717,,
393,New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer,Castillo-Guardiola V;Sarabia-Meseguer MD;Marin-Vera M;Sanchez-Bermudez AI;Alonso-Romero JL;Noguera-Velasco JA;Ruiz-Espejo F;,2018,Cancer Genet,,1,4,30553462,,
394,Clinical genetic testing outcome with multi-gene panel in Asian patients with multiple primary cancers,Chan GHJ;Ong PY;Low JJH;Kong HL;Ow SGW;Tan DSP;Lim YW;Lim SE;Lee SC;,2018,Oncotarget,9,30649,30660,30093976,,
395,Clinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours,Chan SH;Chew W;Ishak NDB;Lim WK;Li ST;Tan SH;Teo JX;Shaw T;Chang K;Chen Y;Iyer P;Tan EEK;Seng MS;Chan MY;Tan AM;Low SYY;Soh SY;Loh AHP;Ngeow J;,2018,NPJ Genom Med,3,30,,30455982,,
396,"Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil",Cipriano NM;de Brito AM;de Oliveira ES;de Faria FC;Lemos S;Rodrigues AN;de Oliveira LD;Dos Santos LL;,2018,Breast Cancer,,,,30535581,,
397,High Yield of Pathogenic Germline Mutations Causative or Likely Causative of the Cancer Phenotype in Selected Children with Cancer,Diets IJ;Waanders E;Ligtenberg MJ;van Bladel DAG;Kamping EJ;Hoogerbrugge PM;Hopman S;Olderode-Berends MJ;Gerkes EH;Koolen DA;Marcelis C;Santen GW;van Belzen MJ;Mordaunt D;McGregor L;Thompson E;Kattamis A;Pastorczak A;Mlynarski W;Ilencikova D;van Silfhout,2018,Clin Cancer Res,24,1594,1603,29351919,,
398,Germline mutations in young non-smoking women with lung adenocarcinoma,Donner I;Katainen R;Sipila LJ;Aavikko M;Pukkala E;Aaltonen LA;,2018,Lung Cancer,122,76,82,30032850,,
399,Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies,Drazer MW;Kadri S;Sukhanova M;Patil SA;West AH;Feurstein S;Calderon DA;Jones MF;Weipert CM;Daugherty CK;Ceballos-Lopez AA;Raca G;Lingen MW;Li Z;Segal JP;Churpek JE;Godley LA;,2018,Blood Adv,2,146,150,29365323,,
400,Clinical spectrum of Li-Fraumeni syndrome/Li-Fraumeni-like syndrome in Brazilian individuals with the TP53 p.R337H mutation1,Ferreira AM;Brondani VB;Helena VP;Charchar HLS;Zerbini MCN;Leite LAS;Hoff AO;Latronico AC;Mendonca BB;Diz MDPE;de Almeida MQ;Fragoso MCBV;,2019,J Steroid Biochem Mol Biol,190,250,255,30974190,,
401,Men seeking counselling in a Breast Cancer Risk Evaluation Clinic,Freitas AC;Opiniao A;Fragoso S;Nunes H;Santos M;Clara A;Bento S;Luis A;Silva J;Moura C;Filipe B;Machado P;Santos S;Andre S;Rodrigues P;Parreira J;Vaz F;,2018,Ecancermedicalscience,12,804,,29456621,,
403,Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population,Gallardo-Alvarado LN;Tusie-Luna MT;Tussie-Luna MI;Diaz-Chavez J;Segura YX;Bargallo-Rocha E;Villarreal C;Herrera-Montalvo LA;Herrera-Medina EM;Cantu-de Leon DF;,2019,BMC Cancer,19,118,,30709381,,
406,Germline mutation in the TP53 gene in uveal melanoma,Hajkova N;Hojny J;Nemejcova K;Dundr P;Ulrych J;Jirsova K;Glezgova J;Ticha I;,2018,Sci Rep,8,7618,,29769598,,
407,Identification and characterization of TP53 gene Allele Dropout in Li-Fraumeni syndrome and Oral cancer cohorts,Haque MM;Kowtal P;Sarin R;,2018,Sci Rep,8,11705,,30076369,Direct submission of data by Rajiv Sarin on 10 July 2019,
408,Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes,Henn J;Spier I;Adam RS;Holzapfel S;Uhlhaas S;Kayser K;Plotz G;Peters S;Aretz S;,2019,Hered Cancer Clin Pract,17,5,,30680046,,
410,Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer,Hu C;Hart SN;Polley EC;Gnanaolivu R;Shimelis H;Lee KY;Lilyquist J;Na J;Moore R;Antwi SO;Bamlet WR;Chaffee KG;DiCarlo J;Wu Z;Samara R;Kasi PM;McWilliams RR;Petersen GM;Couch FJ;,2018,JAMA,319,2401,2409,29922827,,
411,Gene aberration profile of tumors of adolescent and young adult females,Kanke Y;Shimomura A;Saito M;Honda T;Shiraishi K;Shimada Y;Watanabe R;Yoshida H;Yoshida M;Shimizu C;Takahashi K;Totsuka H;Ogiwara H;Hirose S;Kono K;Tamura K;Okamoto A;Kinoshita T;Kato T;Kohno T;,2018,Oncotarget,9,6228,6237,29464067,,
413,Germ line TP53 mutation in a patient with multiple Bowen's disease,Hatta N;Hatta Y;,2018,J Dermatol,,,,30592087,,
414,Gray Zone Lymphoma Arising in the Neck of a Teenager With a Germline Mutation in TP53,Gatineau-Sailliant S;Turcotte K;Quintal MC;Turpin S;Champagne J;Petrella T;Roussy M;Cellot S;Bouron-Dal SD;,2018,J Pediatr Hematol Oncol,,,,30299350,,
415,Deleterious Germline Mutations Are a Risk Factor for Neoplastic Progression Among High-Risk Individuals Undergoing Pancreatic Surveillance,Abe T;Blackford AL;Tamura K;Ford M;McCormick P;Chuidian M;Almario JA;Borges M;Lennon AM;Shin EJ;Klein AP;Hruban RH;Canto MI;Goggins M;,2019,J Clin Oncol,,,,30883245,,
416,Li-Fraumeni syndrome presenting as cutaneous melanoma in a child: case report and review of literature,Baek YS;Seo JY;Song JY;Lee SY;Kim A;Jeon J;,2019,J Eur Acad Dermatol Venereol,33,,,30653764,,
417,A novel p.Gly187Arg TP53 variant appears to result in Li-Fraumeni syndrome,Doyle MR;Johnston JM;,2018,Pediatr Hematol Oncol,35,203,207,30239254,,
418,Combined steroidogenic characters of fetal adrenal and Leydig cells in childhood adrenocortical carcinoma,Fujisawa Y;Sakaguchi K;Ono H;Yamaguchi R;Kato F;Kagami M;Fukami M;Ogata T;,2016,J Steroid Biochem Mol Biol,159,86,93,26940356,,
419,Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer,Li JY;Jing R;Wei H;Wang M;Xiaowei Q;Liu H;Jian L;Ou JH;Jiang WH;Tian FG;Sheng Y;Li HY;Xu H;Zhang RS;Guan AH;Liu K;Jiang HC;Ren Y;He JJ;Huang W;Liao N;Cai X;Ming J;Ling R;Xu Y;Hu CY;Zhang J;Guo B;Ouyang L;Shuai P;Liu Z;Zhong L;Zeng Z;Zhang T;Xuan Z;Tan X;L,2019,Int J Cancer,144,281,289,29752822,,
420,The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome,Macaulay S;Goodyear QC;Kruger M;Chen W;Essop F;Krause A;,2018,Fam Cancer,17,607,613,29392648,,
421,Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition,Martin-Morales L;Rofes P;Diaz-Rubio E;Llovet P;Lorca V;Bando I;Perez-Segura P;de la Hoya M;Garre P;Garcia-Barberan V;Caldes T;,2018,PLoS One,13,,,30256826,,
422,Clinicopathologic characterization of breast carcinomas in patients with non-BRCA germline mutations: results from a single institution's high-risk population,Meiss AE;Thomas M;Modesitt SC;Ring KL;Atkins KA;Mills AM;,2018,Hum Pathol,82,20,31,29958926,,
423,A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study,Nunziato M;Esposito MV;Starnone F;Diroma MA;Calabrese A;Del M;Buono P;Frasci G;Botti G;D'Aiuto M;Salvatore F;D'Argenio V;,2019,Anal Chim Acta,1046,154,162,30482293,,
424,Discoveries beyond BRCA1/2: Multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world,Ow SGW;Ong PY;Lee SC;,2019,PLoS One,14,,,30875412,,
425,Two cancer-predisposing variants in one family: Incidental finding of a fumarate hydrogenase (FH) germline variant in a family with Li-Fraumeni syndrome,Pahl L;Beier R;von NN;Auber B;Hofs M;Prott EC;Schlegelberger B;Reinhardt D;Steinemann D;,2018,Pediatr Blood Cancer,65,,,29893455,,
426,Identification and Management of TP53 Gene Carriers Detected Through Multigene Panel Testing,Pal T;Brzosowicz J;Valladares A;Wiesner GL;Laronga C;,2017,South Med J,110,643,648,28973705,,
427,Li-Fraumeni syndrome presenting as mucosal melanoma: Case report and treatment considerations,Klein JD;Kupferman ME;,2017,Head Neck,39,,,27726232,,Same family as POW13-1 in RefID 270
428,Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer,Park JS;Lee ST;Nam EJ;Han JW;Lee JY;Kim J;Kim TI;Park HS;,2018,BMC Cancer,18,83,,29338689,,
429,Epidermal Growth Factor Receptor-mutated Lung Cancer as the Initial Manifestation of Germline TP53 Mutation Associated Cancer,Pathak S;Singh SRK;Katiyar V;Mcdunn S;,2018,Cureus,10,,,29854570,,
430,Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer,Paulo P;Maia S;Pinto C;Pinto P;Monteiro A;Peixoto A;Teixeira MR;,2018,PLoS Genet,14,,,29659569,,
433,Primary Cutaneous Leiomyosarcoma Arising in a Patient With Li-Fraumeni Syndrome. A Neoplasm With Unusual Histopathologic Features and Loss of Heterozygosity at TP53 Gene,Sabater-Marco V;Ferrando-Roca F;Morera-Faet A;Garcia-Garcia JA;Bosch SB;Lopez-Guerrero JA;,2017,Am J Dermatopathol,,,,28475508,,
434,Increasing genomic instability during cancer therapy in a patient with Li-Fraumeni syndrome,Schuler N;Palm J;Schmitz S;Lorat Y;Rube CE;,2017,Clin Transl Radiat Oncol,7,71,78,29594232,,
436,Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations,Singh J;Thota N;Singh S;Padhi S;Mohan P;Deshwal S;Sur S;Ghosh M;Agarwal A;Sarin R;Ahmed R;Almel S;Chakraborti B;Raina V;DadiReddy PK;Smruti BK;Rajappa S;Dodagoudar C;Aggarwal S;Singhal M;Joshi A;Kumar R;Kumar A;Mishra DK;Arora N;Karaba A;Sankaran S;Katrag,2018,Breast Cancer Res Treat,170,189,196,29470806,,
437,Additional germline findings from a tumor profiling program,Stjepanovic N;Stockley TL;Bedard PL;McCuaig JM;Aronson M;Holter S;Semotiuk K;Leighl NB;Jang R;Krzyzanowska MK;Oza AM;Gupta A;Elser C;Ahmed L;Wang L;Kamel-Reid S;Siu LL;Kim RH;,2018,BMC Med Genomics,11,65,,30092803,,
439,Clinical characteristics and registry-validated extended pedigrees of germline TP53 mutation carriers in Denmark,Stoltze U;Skytte AB;Roed H;Hasle H;Ejlertsen B;Overeem Hansen TV;Schmiegelow K;Gerdes AM;Wadt K;,2018,PLoS One,13,,,29324801,,
440,"Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix",Tandon B;Hagemann IS;Maluf HM;Pfeifer JD;Al-Kateb H;,2017,Int J Gynecol Pathol,36,593,599,28177947,,
441,A germline variant of TP53 in paediatric diffuse leptomeningeal glioneuronal tumour,Tan GIL;Merchant K;Tan EEK;Low DCY;Ng LP;Seow WT;Low SYY;,2019,Childs Nerv Syst,,,,30937530,,
442,Composite Adrenocortical Carcinoma and Neuroblastoma in an Infant With a TP53 Germline Mutation: A Case Report and Literature Review,Tang YJ;Yu TT;Ma J;Zhou Y;Xu M;Gao YJ;,2018,J Pediatr Hematol Oncol,,,,29746440,,
443,Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care,Thompson ER;Rowley SM;Li N;McInerny S;Devereux L;Wong-Brown MW;Trainer AH;Mitchell G;Scott RJ;James PA;Campbell IG;,2016,J Clin Oncol,34,1455,1459,26786923,,
444,De Novo Mutations Activating Germline TP53 in an Inherited Bone-Marrow-Failure Syndrome,Toki T;Yoshida K;Wang R;Nakamura S;Maekawa T;Goi K;Katoh MC;Mizuno S;Sugiyama F;Kanezaki R;Uechi T;Nakajima Y;Sato Y;Okuno Y;Sato-Otsubo A;Shiozawa Y;Kataoka K;Shiraishi Y;Sanada M;Chiba K;Tanaka H;Terui K;Sato T;Kamio T;Sakaguchi H;Ohga S;Kuramitsu M;Ham,2018,Am J Hum Genet,103,440,447,30146126,,
445,Diagnosis of Li-Fraumeni Syndrome: Differentiating TP53 germline mutations from clonal hematopoiesis: Results of the observational AGO-TR1 trial,Weber-Lassalle K;Harter P;Hauke J;Ernst C;Kommoss S;Marme F;Weber-Lassalle N;Prieske K;Dietrich D;Borde J;Pohl-Rescigno E;Reuss A;Ataseven B;Engel C;Stingl JC;Schmutzler RK;Hahnen E;,2018,Hum Mutat,39,2040,2046,30216591,,
446,Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation,Yamazaki F;Shima H;Osumi T;Narumi S;Kuroda T;Shimada H;,2018,J Pediatr Hematol Oncol,40,,,28902083,,
447,"Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer",Yurgelun MB;Chittenden AB;Morales-Oyarvide V;Rubinson DA;Dunne RF;Kozak MM;Qian ZR;Welch MW;Brais LK;Da SA;Bui JL;Yuan C;Li T;Li W;Masuda A;Gu M;Bullock AJ;Chang DT;Clancy TE;Linehan DC;Findeis-Hosey JJ;Doyle LA;Thorner AR;Ducar MD;Wollison BM;Khalaf N;Pe,2019,Genet Med,21,213,223,29961768,,
448,Multiple primary tumors in a family with Li-Fraumeni syndrome with a TP53 germline mutation identified by next-generation sequencing,Zampiga V;Danesi R;Tedaldi G;Tebaldi M;Cangini I;Pirini F;Pittureri C;Amaducci E;Guidi L;Faedi M;Amadori D;Falcini F;Calistri D;,2016,Int J Biol Markers,31,,,27516001,,
449,Contribution of de novo and mosaic TP53 mutations to Li-Fraumeni syndrome,Renaux-Petel M;Charbonnier F;Thery JC;Fermey P;Lienard G;Bou J;Coutant S;Vezain M;Kasper E;Fourneaux S;Manase S;Blanluet M;Leheup B;Mansuy L;Champigneulle J;Chappe C;Longy M;Sevenet N;Paillerets BB;Guerrini-Rousseau L;Brugieres L;Caron O;Sabourin JC;Tourn,2017,J Med Genet,,,,29070607,Some cases are reported in RefID-187 or RefID-62,
451,"Frequency of pathogenic germline variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in ductal carcinoma in situ diagnosed in women under the age of 50 years",Petridis C;Arora I;Shah V;Megalios A;Moss C;Mera A;Clifford A;Gillett C;Pinder SE;Tomlinson I;Roylance R;Simpson MA;Sawyer EJ;,2019,Breast Cancer Res,21,58,,31060593,,
453,Germline breast cancer susceptibility gene mutations and breast cancer outcomes,Wang YA;Jian JW;Hung CF;Peng HP;Yang CF;Cheng HS;Yang AS;,2018,BMC Cancer,18,315,,29566657,,
454,Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry,Penkert J;Strüwe FJ;Dutzmann CM;Doergeloh BB;Montellier E;Freycon C;Keymling M;Schlemmer HP;Sänger B;Hoffmann B;Gerasimov T;Blattmann C;Fetscher S;Frühwald M;Hettmer S;Kordes U;Ridola V;Kroiss Benninger S;Mastronuzzi A;Schott S;Nees J;Prokop A;Redlich A;Seidel MG;Zimmermann S;Pajtler KW;Pfister SM;Hainaut P;Kratz CP,2022,J Hematol Oncol.,15,107,111,35974385,,